Symbol:
SESN3
Name:
sestrin 3
RGD ID:
1319828
HGNC Page
HGNC:23060
Description:
Predicted to enable L-leucine binding activity and oxidoreductase activity, acting on peroxide as acceptor. Involved in cellular response to amino acid starvation; cellular response to glucose starvation; and negative regulation of TORC1 signaling. Located in GATOR2 complex and cytoplasm.
Type:
protein-coding
RefSeq Status:
REVIEWED
Previously known as:
MGC29667; SEST3; sestrin-3
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Sesn3 (sestrin 3)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Sesn3 (sestrin 3)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Chinchilla lanigera (long-tailed chinchilla):
Sesn3 (sestrin 3)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
SESN3 (sestrin 3)
NCBI
Ortholog
Canis lupus familiaris (dog):
SESN3 (sestrin 3)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Sesn3 (sestrin 3)
NCBI
Ortholog
Sus scrofa (pig):
SESN3 (sestrin 3)
HGNC
Ensembl, Inparanoid, NCBI, OrthoDB
Chlorocebus sabaeus (green monkey):
SESN3 (sestrin 3)
NCBI
Ortholog
Heterocephalus glaber (naked mole-rat):
Sesn3 (sestrin 3)
NCBI
Ortholog
Other homologs 2
Mus musculus (house mouse):
Sesn1 (sestrin 1)
HGNC
OrthoMCL
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Sesn3 (sestrin 3)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Sesn3 (sestrin 3)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
sesn3 (sestrin 3)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid|ZFIN)
Caenorhabditis elegans (roundworm):
sesn-1
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
Sesn
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus laevis (African clawed frog):
sesn3.S
Alliance
DIOPT (Xenbase)
Xenopus laevis (African clawed frog):
sesn3.L
Alliance
DIOPT (Xenbase)
Xenopus tropicalis (tropical clawed frog):
sesn3
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 11 95,165,513 - 95,232,475 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 11 95,165,513 - 95,232,541 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 11 94,898,677 - 94,965,639 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 11 94,545,781 - 94,603,894 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 11 94,545,780 - 94,603,894 NCBI Celera 11 92,194,063 - 92,252,174 (-) NCBI Celera Cytogenetic Map 11 q21 NCBI HuRef 11 90,963,643 - 91,030,664 (-) NCBI HuRef CHM1_1 11 94,781,781 - 94,848,813 (-) NCBI CHM1_1 T2T-CHM13v2.0 11 95,172,632 - 95,239,638 (-) NCBI T2T-CHM13v2.0
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
SESN3 Human (+)-catechin multiple interactions EXP 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of SESN3 mRNA CTD PMID:24763279 SESN3 Human (-)-epigallocatechin 3-gallate increases expression EXP 6480464 epigallocatechin gallate results in increased expression of SESN3 mRNA CTD PMID:35701726 SESN3 Human (1->4)-beta-D-glucan multiple interactions ISO RGD:1551273 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SESN3 mRNA CTD PMID:36331819 SESN3 Human 1,1-dichloroethene increases expression ISO RGD:1551273 6480464 vinylidene chloride results in increased expression of SESN3 mRNA CTD PMID:26682919 SESN3 Human 1,2-dimethylhydrazine decreases expression ISO RGD:1551273 6480464 1,2-Dimethylhydrazine results in decreased expression of SESN3 mRNA CTD PMID:22206623 SESN3 Human 17alpha-ethynylestradiol increases expression ISO RGD:1309470 6480464 Ethinyl Estradiol results in increased expression of SESN3 mRNA CTD PMID:29097150 SESN3 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SESN3 mRNA; [Estradiol co-treated with TGFB1 more ... CTD PMID:20660070|PMID:30165855 SESN3 Human 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of SESN3 mRNA CTD PMID:31614463 SESN3 Human 17beta-estradiol multiple interactions ISO RGD:1309470 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SESN3 mRNA CTD PMID:26496021 SESN3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SESN3 mRNA CTD PMID:22298810 SESN3 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1309470 6480464 Tetrachlorodibenzodioxin results in decreased expression of SESN3 mRNA CTD PMID:33387578 SESN3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1309470 6480464 Tetrachlorodibenzodioxin affects the expression of SESN3 mRNA CTD PMID:34747641 SESN3 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551273 6480464 Tetrachlorodibenzodioxin affects the expression of SESN3 mRNA CTD PMID:21570461 SESN3 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SESN3 mRNA CTD PMID:20106945|PMID:21632981 SESN3 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1309470 6480464 Tetrachlorodibenzodioxin results in increased expression of SESN3 mRNA CTD PMID:21215274 SESN3 Human 3-chloropropane-1,2-diol increases expression ISO RGD:1309470 6480464 alpha-Chlorohydrin results in increased expression of SESN3 mRNA CTD PMID:28522335 SESN3 Human 4,4'-sulfonyldiphenol decreases expression ISO RGD:1551273 6480464 bisphenol S results in decreased expression of SESN3 mRNA CTD PMID:39298647 SESN3 Human 4-hydroxyphenyl retinamide decreases expression ISO RGD:1551273 6480464 Fenretinide results in decreased expression of SESN3 mRNA CTD PMID:28973697 SESN3 Human 8-Br-cAMP increases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SESN3 mRNA CTD PMID:20147733 SESN3 Human acetamide increases expression ISO RGD:1309470 6480464 acetamide results in increased expression of SESN3 mRNA CTD PMID:31881176 SESN3 Human acrylamide decreases expression ISO RGD:1309470 6480464 Acrylamide results in decreased expression of SESN3 mRNA CTD PMID:28959563 SESN3 Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of SESN3 protein CTD PMID:20106945 SESN3 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SESN3 mRNA CTD PMID:27153756 SESN3 Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of SESN3 gene CTD PMID:27153756 SESN3 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of SESN3 mRNA CTD PMID:33167477 SESN3 Human amphetamine decreases expression ISO RGD:1309470 6480464 Amphetamine results in decreased expression of SESN3 mRNA CTD PMID:30779732 SESN3 Human belinostat increases expression EXP 6480464 belinostat results in increased expression of SESN3 mRNA CTD PMID:26272509 SESN3 Human benzo[a]pyrene decreases expression ISO RGD:1551273 6480464 Benzo(a)pyrene results in decreased expression of SESN3 mRNA CTD PMID:21569818 SESN3 Human benzo[a]pyrene decreases methylation ISO RGD:1551273 6480464 Benzo(a)pyrene results in decreased methylation of SESN3 exon; Benzo(a)pyrene results in decreased methylation of SESN3 more ... CTD PMID:27901495 SESN3 Human beta-lapachone decreases expression EXP 6480464 beta-lapachone results in decreased expression of SESN3 mRNA CTD PMID:38218311 SESN3 Human bisphenol A multiple interactions ISO RGD:1309470 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SESN3 mRNA CTD PMID:26496021 SESN3 Human bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SESN3 gene CTD PMID:31601247 SESN3 Human bisphenol A decreases expression ISO RGD:1309470 6480464 bisphenol A results in decreased expression of SESN3 mRNA CTD PMID:32145629 SESN3 Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SESN3 mRNA CTD PMID:29275510 SESN3 Human bisphenol A increases expression ISO RGD:1309470 6480464 bisphenol A results in increased expression of SESN3 mRNA CTD PMID:29097150 SESN3 Human bisphenol A affects expression ISO RGD:1309470 6480464 bisphenol A affects the expression of SESN3 mRNA CTD PMID:25181051 SESN3 Human bisphenol F increases expression ISO RGD:1551273 6480464 bisphenol F results in increased expression of SESN3 mRNA CTD PMID:38685157 SESN3 Human cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of SESN3 mRNA CTD PMID:21120746 SESN3 Human capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of SESN3 mRNA CTD PMID:36044967 SESN3 Human carbon nanotube decreases expression ISO RGD:1551273 6480464 Nanotubes, Carbon analog results in decreased expression of SESN3 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681|PMID:25620056 SESN3 Human chlorpyrifos decreases expression ISO RGD:1551273 6480464 Chlorpyrifos results in decreased expression of SESN3 mRNA CTD PMID:37019170 SESN3 Human choline multiple interactions ISO RGD:1551273 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... CTD PMID:20938992 SESN3 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of SESN3 mRNA CTD PMID:27594783 SESN3 Human copper atom multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in increased expression of SESN3 mRNA CTD PMID:30911355 SESN3 Human copper(0) multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in increased expression of SESN3 mRNA CTD PMID:30911355 SESN3 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of SESN3 mRNA CTD PMID:20106945|PMID:21632981|PMID:27989131 SESN3 Human cytarabine decreases expression EXP 6480464 Cytarabine results in decreased expression of SESN3 mRNA CTD PMID:33770205 SESN3 Human DDT decreases expression ISO RGD:1309470 6480464 DDT results in decreased expression of SESN3 mRNA CTD PMID:30207508 SESN3 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of SESN3 mRNA CTD PMID:37042841 SESN3 Human diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of SESN3 mRNA CTD PMID:36621641 SESN3 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 SESN3 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of SESN3 mRNA CTD PMID:29803840 SESN3 Human epoxiconazole increases expression ISO RGD:1551273 6480464 epoxiconazole results in increased expression of SESN3 mRNA CTD PMID:35436446 SESN3 Human ethanol increases expression ISO RGD:1551273 6480464 Ethanol results in increased expression of SESN3 mRNA CTD PMID:30319688 SESN3 Human folic acid multiple interactions ISO RGD:1551273 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... CTD PMID:20938992 SESN3 Human fulvestrant multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SESN3 gene CTD PMID:31601247 SESN3 Human furan increases expression ISO RGD:1309470 6480464 furan results in increased expression of SESN3 mRNA CTD PMID:25539665 SESN3 Human geldanamycin increases expression EXP 6480464 geldanamycin results in increased expression of SESN3 mRNA CTD PMID:26705709 SESN3 Human gentamycin decreases expression ISO RGD:1309470 6480464 Gentamicins results in decreased expression of SESN3 mRNA CTD PMID:33387578 SESN3 Human hydrogen peroxide multiple interactions EXP 6480464 Saponins inhibits the reaction [Hydrogen Peroxide results in decreased expression of SESN3 mRNA] CTD PMID:29274434 SESN3 Human hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of SESN3 mRNA CTD PMID:29274434 SESN3 Human hydroquinone decreases expression EXP 6480464 hydroquinone results in decreased expression of SESN3 mRNA CTD PMID:31256213 SESN3 Human indole-3-methanol affects expression ISO RGD:1309470 6480464 indole-3-carbinol affects the expression of SESN3 mRNA CTD PMID:21396975 SESN3 Human iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of SESN3 mRNA CTD PMID:20368581 SESN3 Human iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of SESN3 mRNA CTD PMID:20368581 SESN3 Human L-methionine multiple interactions ISO RGD:1551273 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... CTD PMID:20938992 SESN3 Human Licochalcone B increases expression EXP 6480464 licochalcone B results in increased expression of SESN3 mRNA CTD PMID:33647349 SESN3 Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of SESN3 mRNA CTD PMID:24449571 SESN3 Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of SESN3 mRNA CTD PMID:26272509|PMID:28001369 SESN3 Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of SESN3 mRNA CTD PMID:28001369 SESN3 Human mifepristone increases expression EXP 6480464 Mifepristone results in increased expression of SESN3 mRNA CTD PMID:17584828 SESN3 Human paracetamol affects expression ISO RGD:1551273 6480464 Acetaminophen affects the expression of SESN3 mRNA CTD PMID:17562736 SESN3 Human paracetamol increases expression ISO RGD:1309470 6480464 Acetaminophen results in increased expression of SESN3 mRNA CTD PMID:33387578 SESN3 Human paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SESN3 mRNA CTD PMID:25458485 SESN3 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SESN3 mRNA CTD PMID:26690555 SESN3 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SESN3 mRNA CTD PMID:21420995 SESN3 Human perfluorononanoic acid decreases expression EXP 6480464 perfluoro-n-nonanoic acid results in decreased expression of SESN3 mRNA CTD PMID:32588087 SESN3 Human perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1551273 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SESN3 mRNA CTD PMID:36331819 SESN3 Human pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 SESN3 Human progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SESN3 mRNA CTD PMID:20660070 SESN3 Human propanal increases expression EXP 6480464 propionaldehyde results in increased expression of SESN3 mRNA CTD PMID:26079696 SESN3 Human quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of SESN3 mRNA CTD PMID:21632981 SESN3 Human resorcinol decreases expression EXP 6480464 resorcinol results in decreased expression of SESN3 mRNA CTD PMID:22623647 SESN3 Human rotenone decreases expression ISO RGD:1309470 6480464 Rotenone results in decreased expression of SESN3 mRNA CTD PMID:28374803 SESN3 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 SESN3 Human simvastatin decreases expression ISO RGD:1551273 6480464 Simvastatin results in decreased expression of SESN3 mRNA CTD PMID:20883752 SESN3 Human sodium arsenate decreases expression ISO RGD:1551273 6480464 sodium arsenate results in decreased expression of SESN3 mRNA CTD PMID:21795629 SESN3 Human sodium arsenate increases expression ISO RGD:1551273 6480464 sodium arsenate results in increased expression of SESN3 mRNA CTD PMID:21795629 SESN3 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of SESN3 mRNA CTD PMID:38568856 SESN3 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SESN3 mRNA CTD PMID:34032870 SESN3 Human Soman increases expression ISO RGD:1309470 6480464 Soman results in increased expression of SESN3 mRNA CTD PMID:19281266 SESN3 Human sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of SESN3 mRNA CTD PMID:31533062 SESN3 Human temozolomide increases expression EXP 6480464 Temozolomide results in increased expression of SESN3 mRNA CTD PMID:31758290 SESN3 Human tetrachloromethane affects expression ISO RGD:1551273 6480464 Carbon Tetrachloride affects the expression of SESN3 mRNA CTD PMID:17484886 SESN3 Human thioacetamide increases expression ISO RGD:1309470 6480464 Thioacetamide results in increased expression of SESN3 mRNA CTD PMID:34492290 SESN3 Human thiram increases expression EXP 6480464 Thiram results in increased expression of SESN3 mRNA CTD PMID:38568856 SESN3 Human titanium dioxide decreases methylation ISO RGD:1551273 6480464 titanium dioxide results in decreased methylation of SESN3 gene; titanium dioxide results in decreased methylation more ... CTD PMID:35295148 SESN3 Human toxaphene increases expression ISO RGD:1309470 6480464 Toxaphene results in increased expression of SESN3 mRNA CTD PMID:23153324 SESN3 Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of SESN3 mRNA CTD PMID:26272509 SESN3 Human trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of SESN3 mRNA CTD PMID:28542535 SESN3 Human triphenyl phosphate increases expression ISO RGD:1309470 6480464 triphenyl phosphate results in increased expression of SESN3 mRNA CTD PMID:30589522 SESN3 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of SESN3 mRNA CTD PMID:37042841 SESN3 Human troglitazone decreases expression ISO RGD:1551273 6480464 troglitazone results in decreased expression of SESN3 mRNA CTD PMID:17569031 SESN3 Human urethane increases expression EXP 6480464 Urethane results in increased expression of SESN3 mRNA CTD PMID:28818685 SESN3 Human valproic acid increases expression ISO RGD:1551273 6480464 Valproic Acid results in increased expression of SESN3 mRNA CTD PMID:21427059 SESN3 Human valproic acid affects splicing ISO RGD:1309470 6480464 Valproic Acid affects the splicing of SESN3 mRNA CTD PMID:29427782 SESN3 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 SESN3 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SESN3 mRNA CTD PMID:26272509 SESN3 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SESN3 mRNA CTD PMID:23179753|PMID:25716160 SESN3 Human vorinostat increases expression EXP 6480464 Vorinostat results in increased expression of SESN3 mRNA CTD PMID:27188386|PMID:33770205 SESN3 Human zinc sulfate decreases expression EXP 6480464 Zinc Sulfate results in decreased expression of SESN3 mRNA CTD PMID:16330358
Imported Annotations - KEGG (archival)
(+)-catechin (EXP) (-)-epigallocatechin 3-gallate (EXP) (1->4)-beta-D-glucan (ISO) 1,1-dichloroethene (ISO) 1,2-dimethylhydrazine (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (EXP,ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 3-chloropropane-1,2-diol (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 8-Br-cAMP (EXP) acetamide (ISO) acrylamide (ISO) aflatoxin B1 (EXP) all-trans-retinoic acid (EXP) amphetamine (ISO) belinostat (EXP) benzo[a]pyrene (ISO) beta-lapachone (EXP) bisphenol A (EXP,ISO) bisphenol F (ISO) cadmium atom (EXP) capsaicin (EXP) carbon nanotube (ISO) chlorpyrifos (ISO) choline (ISO) cisplatin (EXP) copper atom (EXP) copper(0) (EXP) cyclosporin A (EXP) cytarabine (EXP) DDT (ISO) Dibutyl phosphate (EXP) diethylstilbestrol (EXP) dorsomorphin (EXP) doxorubicin (EXP) epoxiconazole (ISO) ethanol (ISO) folic acid (ISO) fulvestrant (EXP) furan (ISO) geldanamycin (EXP) gentamycin (ISO) hydrogen peroxide (EXP) hydroquinone (EXP) indole-3-methanol (ISO) iron atom (EXP) iron(0) (EXP) L-methionine (ISO) Licochalcone B (EXP) methotrexate (EXP) methylmercury chloride (EXP) mifepristone (EXP) paracetamol (EXP,ISO) perfluorononanoic acid (EXP) perfluorooctane-1-sulfonic acid (ISO) pirinixic acid (EXP) progesterone (EXP) propanal (EXP) quercetin (EXP) resorcinol (EXP) rotenone (ISO) SB 431542 (EXP) simvastatin (ISO) sodium arsenate (ISO) sodium arsenite (EXP) Soman (ISO) sunitinib (EXP) temozolomide (EXP) tetrachloromethane (ISO) thioacetamide (ISO) thiram (EXP) titanium dioxide (ISO) toxaphene (ISO) trichostatin A (EXP) triphenyl phosphate (EXP,ISO) troglitazone (ISO) urethane (EXP) valproic acid (EXP,ISO) vorinostat (EXP) zinc sulfate (EXP)
SESN3 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 11 95,165,513 - 95,232,475 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 11 95,165,513 - 95,232,541 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 11 94,898,677 - 94,965,639 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 11 94,545,781 - 94,603,894 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 11 94,545,780 - 94,603,894 NCBI Celera 11 92,194,063 - 92,252,174 (-) NCBI Celera Cytogenetic Map 11 q21 NCBI HuRef 11 90,963,643 - 91,030,664 (-) NCBI HuRef CHM1_1 11 94,781,781 - 94,848,813 (-) NCBI CHM1_1 T2T-CHM13v2.0 11 95,172,632 - 95,239,638 (-) NCBI T2T-CHM13v2.0
Sesn3 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 14,187,597 - 14,237,430 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 14,186,363 - 14,244,397 (+) Ensembl GRCm39 Ensembl GRCm38 9 14,276,301 - 14,326,134 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 14,275,067 - 14,333,101 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 14,080,745 - 14,130,578 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 9 14,026,802 - 14,076,531 (+) NCBI MGSCv36 mm8 Celera 9 11,556,960 - 11,606,787 (+) NCBI Celera Cytogenetic Map 9 A1 NCBI cM Map 9 3.89 NCBI
Sesn3 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 19,415,307 - 19,470,943 (+) NCBI GRCr8 mRatBN7.2 8 11,133,822 - 11,189,436 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 11,133,678 - 11,185,842 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 15,127,233 - 15,175,350 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 13,424,974 - 13,473,087 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 11,401,822 - 11,451,054 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 12,823,060 - 12,878,749 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 12,823,155 - 12,872,705 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 12,768,558 - 12,824,247 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 11,076,055 - 11,125,523 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 11,076,056 - 11,124,656 (+) NCBI Celera 8 12,629,794 - 12,679,054 (+) NCBI Celera Cytogenetic Map 8 q12 NCBI
Sesn3 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955412 107,861 - 125,944 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955412 100,335 - 125,395 (-) NCBI ChiLan1.0 ChiLan1.0
SESN3 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 9 96,024,992 - 96,091,563 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 11 97,116,421 - 97,183,065 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 11 90,184,571 - 90,249,825 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 11 93,707,191 - 93,773,762 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 11 93,714,916 - 93,773,679 (-) Ensembl panpan1.1 panPan2
SESN3 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 21 5,827,957 - 5,899,540 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 21 5,777,780 - 5,892,805 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 21 5,838,876 - 5,910,413 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 21 6,009,357 - 6,080,923 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 21 6,009,392 - 6,076,112 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 21 5,797,473 - 5,868,971 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 21 5,859,251 - 5,930,864 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 21 5,907,109 - 5,978,669 (+) NCBI UU_Cfam_GSD_1.0
Sesn3 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404947 80,057,455 - 80,116,144 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936700 2,429,446 - 2,488,127 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936700 2,429,535 - 2,491,752 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
SESN3 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 9 27,207,236 - 27,298,628 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 9 27,207,239 - 27,279,205 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 9 31,044,963 - 31,076,106 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SESN3 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 1 86,426,258 - 86,486,465 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 1 86,427,988 - 86,486,477 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666043 39,312,039 - 39,377,416 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Sesn3 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 3142 Count of miRNA genes: 1217 Interacting mature miRNAs: 1525 Transcripts: ENST00000278499, ENST00000393234, ENST00000416495, ENST00000536441, ENST00000537480, ENST00000542176 Prediction methods: Microtar, Miranda, Rnahybrid Result types: miRGate_prediction
407209456 GWAS858432_H eosinophil count QTL GWAS858432 (human) 5e-09 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 11 95169007 95169008 Human 596974701 GWAS1094220_H 2-O-methylascorbic acid measurement, sex interaction measurement QTL GWAS1094220 (human) 0.000005 2-O-methylascorbic acid measurement, sex interaction measurement 11 95203556 95203557 Human 597132622 GWAS1228696_H 2-O-methylascorbic acid measurement, sex interaction measurement QTL GWAS1228696 (human) 0.000005 2-O-methylascorbic acid measurement, sex interaction measurement 11 95203556 95203557 Human
RH46209
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,914,549 - 94,914,725 UniSTS GRCh37 Build 36 11 94,554,197 - 94,554,373 RGD NCBI36 Celera 11 92,202,479 - 92,202,655 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 90,979,515 - 90,979,691 UniSTS GeneMap99-GB4 RH Map 11 318.3 UniSTS
WI-16429
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,959,583 - 94,959,697 UniSTS GRCh37 Build 36 11 94,599,231 - 94,599,345 RGD NCBI36 Celera 11 92,247,513 - 92,247,627 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 91,024,547 - 91,024,661 UniSTS GeneMap99-GB4 RH Map 11 317.37 UniSTS Whitehead-RH Map 11 417.5 UniSTS
D11S2315E
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,899,936 - 94,900,009 UniSTS GRCh37 Build 36 11 94,539,584 - 94,539,657 RGD NCBI36 Celera 11 92,187,866 - 92,187,939 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 90,964,901 - 90,964,974 UniSTS GeneMap99-GB4 RH Map 11 319.17 UniSTS NCBI RH Map 11 794.1 UniSTS
D11S361
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,960,201 - 94,960,385 UniSTS GRCh37 Build 36 11 94,599,849 - 94,600,033 RGD NCBI36 Celera 11 92,248,131 - 92,248,315 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 91,025,165 - 91,025,348 UniSTS
SHGC-111463
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,952,122 - 94,952,372 UniSTS GRCh37 Build 36 11 94,591,770 - 94,592,020 RGD NCBI36 Celera 11 92,240,052 - 92,240,302 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 91,017,088 - 91,017,334 UniSTS TNG Radiation Hybrid Map 11 42107.0 UniSTS
SHGC-111507
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,952,673 - 94,952,889 UniSTS GRCh37 Build 36 11 94,592,321 - 94,592,537 RGD NCBI36 Celera 11 92,240,603 - 92,240,819 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 91,017,635 - 91,017,851 UniSTS TNG Radiation Hybrid Map 11 42107.0 UniSTS
RH68616
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,929,706 - 94,929,879 UniSTS GRCh37 Build 36 11 94,569,354 - 94,569,527 RGD NCBI36 Celera 11 92,217,636 - 92,217,809 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 90,994,683 - 90,994,856 UniSTS GeneMap99-GB4 RH Map 11 319.17 UniSTS NCBI RH Map 11 794.1 UniSTS
D11S4631
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,921,944 - 94,922,137 UniSTS GRCh37 Build 36 11 94,561,592 - 94,561,785 RGD NCBI36 Celera 11 92,209,874 - 92,210,067 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 90,986,922 - 90,987,115 UniSTS
RH11849
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,898,799 - 94,898,971 UniSTS GRCh37 Build 36 11 94,538,447 - 94,538,619 RGD NCBI36 Celera 11 92,186,729 - 92,186,901 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 90,963,765 - 90,963,937 UniSTS GeneMap99-GB4 RH Map 11 319.17 UniSTS NCBI RH Map 11 794.1 UniSTS
SGC34501
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,902,368 - 94,902,481 UniSTS GRCh37 Build 36 11 94,542,016 - 94,542,129 RGD NCBI36 Celera 11 92,190,298 - 92,190,411 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 90,967,333 - 90,967,446 UniSTS GeneMap99-GB4 RH Map 11 319.17 UniSTS Whitehead-RH Map 11 416.2 UniSTS NCBI RH Map 11 794.1 UniSTS
RH18334
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,898,805 - 94,898,992 UniSTS GRCh37 Build 36 11 94,538,453 - 94,538,640 RGD NCBI36 Celera 11 92,186,735 - 92,186,922 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 90,963,771 - 90,963,958 UniSTS GeneMap99-GB4 RH Map 11 319.17 UniSTS NCBI RH Map 11 794.1 UniSTS
RH48984
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,906,271 - 94,906,411 UniSTS GRCh37 Build 36 11 94,545,919 - 94,546,059 RGD NCBI36 Celera 11 92,194,201 - 92,194,341 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 90,971,236 - 90,971,376 UniSTS GeneMap99-GB4 RH Map 11 319.17 UniSTS NCBI RH Map 11 794.1 UniSTS
RH47318
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,902,410 - 94,902,553 UniSTS GRCh37 Build 36 11 94,542,058 - 94,542,201 RGD NCBI36 Celera 11 92,190,340 - 92,190,483 RGD Cytogenetic Map 11 q21 UniSTS HuRef 11 90,967,375 - 90,967,518 UniSTS GeneMap99-GB4 RH Map 11 319.17 UniSTS NCBI RH Map 11 794.1 UniSTS
G33064
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,940,114 - 94,940,280 UniSTS GRCh37 Celera 11 92,228,044 - 92,228,210 UniSTS Cytogenetic Map 11 q21 UniSTS HuRef 11 91,005,090 - 91,005,256 UniSTS
A010B04
Human Assembly Chr Position (strand) Source JBrowse GRCh37 11 94,940,114 - 94,940,280 UniSTS GRCh37 Celera 11 92,228,044 - 92,228,210 UniSTS Cytogenetic Map 11 q21 UniSTS HuRef 11 91,005,090 - 91,005,256 UniSTS GeneMap99-GB4 RH Map 11 319.17 UniSTS NCBI RH Map 11 794.1 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
entire extraembryonic component
1204
2430
2788
2246
4953
1724
2344
3
622
1937
464
2265
7279
6449
51
3719
850
1734
1611
174
1
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENST00000278499 ⟹ ENSP00000278499
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 11 95,173,148 - 95,232,541 (-) Ensembl
Ensembl Acc Id:
ENST00000416495 ⟹ ENSP00000407008
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 11 95,184,135 - 95,231,046 (-) Ensembl
Ensembl Acc Id:
ENST00000536441 ⟹ ENSP00000441927
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 11 95,165,513 - 95,231,202 (-) Ensembl
Ensembl Acc Id:
ENST00000537480
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 11 95,191,565 - 95,232,475 (-) Ensembl
Ensembl Acc Id:
ENST00000542176 ⟹ ENSP00000439580
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 11 95,191,465 - 95,232,527 (-) Ensembl
Ensembl Acc Id:
ENST00000634898 ⟹ ENSP00000489281
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 11 95,189,819 - 95,232,518 (-) Ensembl
RefSeq Acc Id:
NM_001271594 ⟹ NP_001258523
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 11 95,165,513 - 95,232,475 (-) NCBI HuRef 11 90,963,643 - 91,030,664 (-) NCBI CHM1_1 11 94,781,781 - 94,848,813 (-) NCBI T2T-CHM13v2.0 11 95,172,632 - 95,239,586 (-) NCBI
Sequence:
AGTGAGCACAGAGCTCCTTGCCAGTAGGCGATGCAAGTTATCTCTGGGGCCCGGAGGACACGAGTGAGGACCGGGCACCAATCAGGTTCTCGCTCTGCGCCGGCCTTTGTTCTCACTCGGGAGCAGGT TGCGGGCGTCTAGCATCGGGAACCCGCATTCGACTCGGACGCGCATTGCTAGCCCCTTCGGGAGACCTGGCTCCCCTACCCGTCTGTCCCGCCACACTCGGTCAGCCTGCGCTTTCCCCAGTCAAGTC TGCCTTCTCTCCGCAGAACGTGGACGCTAAAACCCTGACTTACCATTTTAAGCTTTAGAAGAGGATAAAAGAATCAGAGTGTCTCAACCCTTGACAAGAGGACCAAGTGCCTTTATTCCAGAGAAGGA AGTTGTCCAAGCAAACACAGTGGATGAACGTACTAACTTTCTTGTGGAAGAATACTCTACATCCGGTCGTCTGGACAACATCACACAGGTCATGAGTTTACACACTCAGTACCTGGAGTCTTTCTTGC GGAGCCAGTTTTACATGTTGCGCATGGATGGTCCCCTTCCTCTACCATACAGGCACTATATTGCAATAATGAAACTTGTCAAAACTGGAGAAAATAATTGGTCTCTGCCTGAACTGGTACATGCTGTG GTCCTCCTGGCACATTATCATGCTTTGGCAAGCTTTGTTTTTGGTAGTGGTATCAATCCAGAGAGAGATCCAGAAATCTCCAATGGATTCAGGCTAATATCAGTCAACAATTTCTGCGTTTGTGATCT TGCTAATGACAACAACATAGAGAATGCATCTCTTTCAGGCAGCAACTTTGGGATTGTGGATTCTCTAAGTGAGCTAGAGGCCTTAATGGAAAGGATGAAAAGACTTCAAGAAGAAAGGGAAGATGAAG AGGCGTCTCAAGAAGAAATGAGCACTCGTTTTGAAAAGGAGAAGAAAGAAAGTCTTTTTGTGGTCTCTGGAGATACTTTTCATTCATTTCCTCATTCAGATTTTGAGGATGACATGATTATAACATCT GATGTCTCTCGATATATTGAAGACCCTGGTTTTGGGTATGAAGACTTTGCCAGACGAGGAGAAGAGCATTTGCCAACATTCCGAGCTCAGGACTATACCTGGGAAAATCATGGGTTCTCCCTGGTGAA CAGACTTTATTCTGACATTGGACATCTTCTTGATGAAAAGTTTCGGATGGTCTACAATCTCACATATAACACTATGGCCACCCATGAGGATGTTGACACAACCATGCTGCGCAGAGCTTTATTTAACT ATGTTCACTGTATGTTTGGAATCAGGTATGATGACTATGATTATGGAGAAGTTAATCAATTACTTGAAAGAAGCCTGAAGGTTTACATTAAGACAGTGACCTGCTATCCTGAGAGAACTACAAAACGC ATGTATGATAGTTACTGGCGGCAGTTCAAACACTCAGAAAAAGTTCATGTCAATCTACTTTTAATGGAAGCACGAATGCAAGCTGAACTTCTTTATGCTCTTCGTGCCATAACTCGGCATTTGACCTG AAGTATCACCCAAGGAAAATGTCATACATGTGTAAAGACCTTTCACATAAGATAAACATTGAAGCTATTTGTGATATAGCATCAAAAATTATTCAGTTCTCTAGTGTCAAAGTTTAGCCGTTTGTTTT TTTTTTTTTGTTTTTTGCGGCTGTAATGTGCAATGATGTGTTTTATTTTCCTTGATGCTTAACATTACTAACAATTGCAAAAATAATACTGAGGAGCACTACTTTGCATTGTTTGTAGTTGGAGTTTT GGATACTGATCATAAATCATGAATCTGGCGTATTAATGCTTAACTTCAGCGCCTTTGGGTTGTGTGTATGTGTATTTTTTCTCCCCCCACCCCGCCCTTTTTTTTTTAAGAATAAGGACAAGTGCTTA CAATCTGCTCAAGCAATTGTTTTTCAGATATTGGAATTCAGCAAAGAGTGACCTCTCTGGCCATTCTAAAACTTTAATGTTGTGTCCTAAATCTGGTGGAGGAAAAGCATGCGCTGTTGAACCAAGCT GCTCACTGGACACATATTTGTGTCCCCAGGAGATTATTTGTCAGGCACTGTTTTTTATTTGTTTGTTTGTTCATTTATTGTTGTTTTACTGCTATTGGCGATAACATGAAATGTGATACAGCTATTGC CCATAATTTAATGTGAAATTAATCATGATGAATTCTATAGCATGCTACTGAAATGCCAAATTCAGCTATTTTCTTTCTCTTCTAAAATGGAAGTTTCAGTTTTCCATATCAGATGTATATAAGTGGAA TTATAACACAATCCTATCACTGACAGTAATCCTCAGTCACCTTAAATAATCAGTGCTCACAGTGCTGCTTACAGTTCATTTAGTTGGCACATATAAACCTGTACCCACACAAGACTGACCAAAAATTT TCTTTGCACATTTTTCCTTTCTCATAGTTTTTTTCTATATTTCGTTAAGCAAAGGAAGGTTAATATGCCTATTTTTCCTGTTAGGCTTTTAGAAATTATTTTCCATGACTTTTGTTCTTATAATAGGT TAGACAGTTTATTTTTCAAAGGTAAAAATTGTGTTTCTATGCATTAATGTGATTGAACTACAAAAACAGAGTGCAATATGTTCAAAAAATACTCAACTAAACTTTCCCCCTGTCATATCACTGCAAAA GTGTCCTTTTAAACAGAGCCATAAAGAAATTTTTTTCAAATTTCTTTATTGCACAGGCTTTTTTCAGTTTTACCTTTCTGGGATTGAACAATGTTCCTTTCATAATGCCAAAGCATTCCCTTCCCCAG AAAAATCTCCTTGGACAACTGGTTTAAAAACGTTATTAAGTCATAGGGGAGGAATAAGCGGCCAAAAAGTCACATTTTTGCATTGGTTTACGTTGCTTGATTAGACTATCTTCAGAGAGCACATTATG TGTTTATAGCTTTAATTTGTATTATGTCAATGAACCAGTGAAGTGCCTAAAGAGATGCTTACAACTATCCAGTAGGACACAACTGCACTGCTTTTTAAACACTTTTTGGTTAGTTAAGGGTGACTTGA ATTGTACACATACATGCTAATTTTTGAAAACTTATCCATTTTTCATAGTAAATAATATAGATAAAATTTTCTGTTAGAGTTCCCGCAAATATTTCATTTTAGACTTACTTGTGATATAAGATTTAACT TTTCTTTTGTGAAAGAATCGTGAACTAGTGTTTCATGAAATCATTTTCCTCTTCCATTTATCATCCTCCTCTGGTACAATATATTGGGTTGCTTTCTTTTAGATTTTGTTCCAGATAGGAAAACAAAT ATGACTGTATACTTATTAACATAAGGTAGTTCTGCATTTTTGGATTCCAGGATCCTGTTTGAAATCTTCCATGTGAGGAAAAAATTACTAATATTTTTAAAGACAGGGTGGTTTATTTAAAGAGATTA TTCAGAGAACTTGTGCCATATCTCGTCTGTTTTATTGCATATGCCATATGTTAACTTTTATTCAATATTACATTATGTAGATATGTAATACAAAGAAAATATTTAGGAGAATGGCAAAACACAAATGG CAACATAAATGTCCATTTGACTTACCTAACTTCACAACTTTCAAGTTGAGGATGTCATTTATTCTTGAATTTGTTTTTTTACTAGATGCTTTCAATTAATAGCCCTATATTTTTGTGCAGGCGAACTG TATAACAGGATAAAAAATGATTTGTATGTATTGAAAAGGAGGAGAAATTCTCACAGAACACCATATGAGCTTTAGACCAAAAGGGGAAACAAGGTTTAAGTAACTAAAATGGCCACTTAGTTTGTGTT TATTTTTTTCCCTGGAAATGTAAGTAGTTGGAGTTTAGGCTATGGAAATATTAGTGCCTTTAATAGATCTCTTTCCTTGCAAAGTTTCTTTTTAGCTCAGCATTGATCTATCTTATCAATAGGAAAAT AAGTTGACTTGGAACTATAAACAAAAACAACACCATATATTTATGAACCTCAGTGAACCAGCCTAGAAAAATTGACTTCTGCAGGTGCTAAAGCACCTACTAATACGCAGCATGCACAGCATTTCAGG TTGTGAATACCATTTTACAACGAGTTTGCTGTTAACTCTCTTTATCCAATGCAAACTTGAAATTCTGATGCGGTTTTCCAGGGTGGTATTTTTTCAGAGTATTGAATTTACTATTTAGTAATTTATAG TATAGCTTTTTATATTAAAATGTGATATTTTTAAAAGAGATATCTGGTTCAATTGGTATAATGACGTGATTATGCAATATGCTGATCTACACCTTGCGCTCACATTGTGCCAAACTTAAATGTGCAAG TGTACGTGAGAAAAGCACATGTGAATGTGAATTCTTTAATTCTTTGCTTATTATGTTAAAATTAGTCTTCATAGTCCACTGATGTGTATGCTTGAATAATGTCTATTTACTTTGGAATTTCAAGATTT CCAGCTTCAATGGTAATTTATAATTTCTCAGATCACCTTAAGAAATATTGAGATACTCTCCCACCTGAAAATAATCTGTTCTTTAACCCACCTGACTATGGGAGTAGCCAGGCAGGTGCCTCACTGGC TTCTTCAGACGAGGCTTCCTCAGGTGGATATATGACTATTAGGGGAAAAGAGGCTTTTGAGACAGCTTATTACCTCCTTCCCCTTTTTGAACTAAGTACATTGTCTCAGTCCCAGTATGAATTTGTCC CATTTGGGGTATTTTTAAAATAAAAGATGGCTAACATGGAATCTGGGGCATAGCCTTGGCCTTTAATTATGGTTGTAAGCCCAAATAATGGCAGAGAAACACAGGGCTGTTTTTACAACAGAAAACTC AATATAAGTTTTATATAAGAATCCTATAAAATTTGAACCAGAGCTCCTATTTAGTTGTTATAATGTCTCCTAAAGATCTTAAATGCTTCTAAAAGCTAATTATTATTCCAGAGCAACTTTTTCCTTTT CCCCCTTATAAAGTTTTTTTTTAAATCCAAAATCTTAGATTTCTGTGCCACAGCAAAATAAAATGATCAACAATTAAAGATCTGTACTTAAAATAGTACACCATTTTTAGTGGAGGGAGGGTGCATGC CTATATGATGGTAAGATTCTTTTGAACTCTAAGGACAATTCCTCATGGAAAAAATAAATTTCAGTGCATATTATAAAAATGATTTGCACTGTGTTAGCAAAATAAGGTGTTTTAGGTTGTATTTTAAA GACAATTCTAAATCATTTCTCTGGAAAGCAAGACCTTAAATTCTTCTCTTTAATAGAACTGCTTTTATGCAAAGAGATGGTCTTAACATGGACTAAACAGTACATAACAATAATGTTTGTTATGTAAA TAGTATATCACATTTGCTTAGTAGCACAATTCAACAGCAGGCTGAAAGTCGTGGCTCCTCTGCTCAGATTGAGTTTTAAGTTACCTAATTTATGTAATCAGAATCTATTCTAGGTGGCCGTCAACGTA AACTGTGTTTCCCTATTATATCCCTCTGGAGACTGAGAATCAAATTAAATAGTCTTTCTTCAAAGCAGTACTGTAACATGAATGTATTTATCTCAGTCAACAGAACTTATATGCCCACTGTATGTGGA GCTTATTTCAATGCTAATTTGGCTTAGTTAGCAGACCTAGAATCTGCCCAGGTGAGACCTAGAACAAAAATAGCTGGGGTGAAATGGATAAGAGAGGTAGAGGTATATGTCAAGGCAGAGCCCTATGA GGAAGGAAGAGTTTTCAAAGAATATGAGGAACATAGTGCTGAGAGTGTGGCTGCCTTCAGCACCGTACACCTAATCTAGAGAAAATATTTCCCATGTGGGAGGTCCTGTCTGCATTCAGTCCACCCTT TTCTGCCTGCTTCTTCCTCCAAGTGCCTCAACCTCTACATGCTCACTCTCCTCCCCTTCCCTCAGCCCATCTTGGTCTAAGCAGCTTTCACAATCCAAACCAAACATCACCAGCCACCCGCTGATAAG TCACCAGCATTTACTTTCCTGAGTTACTTTTTCTCCATTCATTGAGACTATGGATTCATCCCAACTCCTTCTAAATCCCTCAACCATCCAGCTATATTTTGGCTAACCTTTGCCCTAGACACTCTACC AGATGTTAATGCAGTATCAAGTGTAAATTGTGTCACCCTATTCTGTTCTACCCTTTTCCCTGCTGCCGAAATATCTTGCTCTCCTCTACCTCATCCCCAAAGAGCCTATAAATTCAGAGTATCCAACC TTTTCATGGATTCACTCACTGTTGTTCAGTAATACAACTTCCATATTTTAAATAAATCATAAAAGATTTTTGCCTTCTATCAAAGTAGGAAACTTTATATTTATACATGATACAGAAATTGAACTATT TCTATCGTTCAGAATTTAGCATATAACAGGATTTTAAAGTGATTGAATTGCCATCCTAACTTGGATTTGTATTAGGTTATGAATGAATACTGTTGTTAGTCCAAGCTATTTGAATGTAAAGTTAAAAT TCTCCAGCAATCCAGAATGACTTGTAACCCTTCAGTGGAATGGGAAATTTCTGGTATGCAAATAGGGTGGTGTTCCAGACATTTGTTTTATTGGTGGTGTTTGGGCCTTGAAACACATTTCTAATAGA ATGACATATGGCAAAGGGTATTTAGATGGTCCTATGGGATCACAGAAGCCCATATGATTTAAAATATAGATAAAATAACACAAAATTGGGTACATAAGGGTTTAACCAGGCTTTCCTGGGTTAGACTA AGCCTCTAACCTCTGTTCCTATCCTGTTCTTATGGGAGGAAAAAAAATGTTCCATGGGATGAAAAGAAAATGCATTGACTTTGTAGTCTTTATTCTCCTAGCCGCACTTCGGGTATATCCAGAAGGAA GAGGAAATGCAAAGAGGAAGAAGATGTAATAGTTCTTCTCTCCAGCTAGGTGCACTTGAGGTTGTTCATAAATGTAAAATTATGTCAGGTTTCTAACATGGGACACTGCACACAGTTGTCTGACCTGA TGAACCATCCCATTTGAAAGTATAGATTATTATTATTTCTTGTAGTATTTGGTTGTTTTCCATCTCATTCATGAACAACTCAACCTGATAGTAGTATCCAATAAATGCCTTTCAGGGCTCAGGAATGA ATTGACATCCTAGTTAAGAAATGAGACTTAATAATGGAGACTGAATGAGGCGGTTTGTATTAAATTATATGCCATGAAGTGTTCATTTTAGCTTTAACCTAATTATGACTGTACCACCATGAAGTACA GAATGAAAAATTATATATATGGGGGGGAAACAGAATGAATATCTGATTCTTTTGAATGCTTGTGGAAATCTTTGAGATCGTGCAGGGCATACCACAAAATAGCCTTTAGAACAGATACCCAATTTTAC AGTTCATAGGACAACATCAAACATTAGTAAGTCTAAATAAGATGAATAGAATTTTTGTTATGTAAATTTTGCTAGAACAGTCTATTTTCTTGCACCCCTCAAGTTAACCTCTTAAAAAAATGAATGTA TAATTTCTACCGAAAGAATATCAGAGAGAATCTCTCTGGCCTATAGTGTTAAAATATTGTTCACAAATCCTGATTAGTTAAGTGCATACATTATGAAACTTACAGAATAAAACTTATTATACATCTCT TTCTTAAATTAATATCTTTACACATTTTCAACTGGCTCCCCAAGTCTGATAAGGAAGGATTAAAAGAAAAAAGAAATGTATTAGTTGGGTGGCCAAGGAGTTTCCTTTGTAATGTTGAGAGACTTCCG CTTTCTGAATTTCGCTGGTTCTCTAAGGTAAAAGAGTTAAATAGTACCCTTGTTCACCAAGGAAAGTGATCCAAACTATATATCTAGTGCAGATATTTCCTTTGCATTATTTAGTCTTCTCTGGAGAG AAAATACAGTTTCCCCTTCCTCTTTCTCTTCACATTTACTCTTTTCAACCCAAAATAAGAGACATAGAAAGCAAACCACAGCCAGTTTGGCATCTTCTCAGTGCTACTAGTATAGGCACATACACATA CACAGTCTCAGCAAGGTTATAAAGAACCCTGTCAGGTCCACTTGCAACATGGCCTTGCTACTTGGATTAGCTCCTTTAAGCCTGAAAATAACTTTCCTGGTCATGGAAGAACTGGACGCATCTTTTAA CTTATGAAATAGAAGTTGAACTTGAAAACTCTTTTTAAAAAATCCTGGTTTTGCAGGACAGCTACATAATGAATGTATATATTAAGACTGTAGCTGAATTGCACATGAAATCAGATTGCCAACTTCTT GACTTTCAATGTTAGACATTTATCCTTAAGTTGTGAGCGATATATGTAGCATGCTGTGAAATGTCTGTTATAGCTCTTTAATTCATCAGTATTAATACAGAATTATCATTTGCGTTTCTTGGTACTTT TTATTCAATGTAATCAGAAGCTGTGATGTTTTGCCTTTGTAGTCCTGTGCTTTGTTACTGTAATTTTTTTTTTTTTTTTACGAAGCACGTGACTGGACTAATGTAAGGCAGATGACGTGATCTTTAAG ACTGCTATATATATCAGTCTCTTACTCTATAAGGTTTTAAATTAGAATAAGCTTTTATCAAATAGATAATTGATGCAATTTAGGATTCACGCAAGTTTCAGTGTCAAATGGCGGTCTTATAGTTTCAA TTCTGAAAATAGCAAACTTAATAAACAGCCACTTTAAACTTGTTCTGGCAAACCAGACCCTGCTGTAGATATAGTCTAAGGTAGTTAACCATATAAGCCTTTTCAACTCTTAATGCCCTCCACATGAA TCAGCAGTTAAGAAGGTTCTAGAACCCATGAAAGCTTTTGTATGTATTACTAGGTTTTGTTTTTCTTATGTTTGCTGATTTTACAGTTCTGACTAAAGCTGACCTAAATGGATCAGTTTATGTGTAAT ATTCTAGTGCTTTAATGACTCTTTTTTTCTTTGGAGGGAGGGTAACATTATTTGGACAGATGCAGAAGGAACTGTTAGTGAGTCAAGACAAACACATCTGAAATAAAGGAACTGTGTATTAACATGTT AACAATTCATAACTGCACTTTTTATGACATTTTGAAAATCTATTTATAGGTACAGAACAATGGGTTTTGTTAAACTGTATCACATTTATACTTGCAGAAATTTATTTCATTGTTATTAGTAGGAATTT TATTGGTTCAATAAAATTGGCAAAACTGAACACCAATCATTTGCCTACTTTGTTTATACTGGA
hide sequence
RefSeq Acc Id:
NM_144665 ⟹ NP_653266
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 11 95,165,513 - 95,231,202 (-) NCBI GRCh37 11 94,898,677 - 94,965,705 (-) NCBI Build 36 11 94,545,781 - 94,603,894 (-) NCBI Archive Celera 11 92,194,063 - 92,252,174 (-) RGD HuRef 11 90,963,643 - 91,030,664 (-) NCBI CHM1_1 11 94,781,781 - 94,847,354 (-) NCBI T2T-CHM13v2.0 11 95,172,632 - 95,238,313 (-) NCBI
Sequence:
GCACTGAGGCGCTGCGGCGGCGGTGGTGGCGGTGGCAGCGGTGGCGGCTGCTCGTCCTAGCCTG GCGGGGGCGGGGGTCTGGAAGATGGGGGCGGGTGGAACAACGGGCCGGTGAGGAGCAGCCGCCGCCGTCTCCGCCGTCGCTGGGGCAGCTGCCGCGGTGGTCGCCTCTGGCAGTGCCGCTAGCTTTCA GGCAGTCGCCTCTCCTCCCGACATCCCGCCTTGAGGAGGCTGAGGCGGAATCGCGGCTGGCGGCGGGGGGACGGACCGGCCCTGCAGTGGCCGCAGTGACAGCCCGGACCCGGCCCTCCGCCCGCTCT CGCCTCGGCGCCCGCAGCCACGATGAACCGGGGCGGCGGCAGCCCGTCGGCCGCCGCCAACTACCTGCTCTGTACCAACTGCCGGAAAGTGCTGCGGAAGGATAAAAGAATCAGAGTGTCTCAACCCT TGACAAGAGGACCAAGTGCCTTTATTCCAGAGAAGGAAGTTGTCCAAGCAAACACAGTGGATGAACGTACTAACTTTCTTGTGGAAGAATACTCTACATCCGGTCGTCTGGACAACATCACACAGGTC ATGAGTTTACACACTCAGTACCTGGAGTCTTTCTTGCGGAGCCAGTTTTACATGTTGCGCATGGATGGTCCCCTTCCTCTACCATACAGGCACTATATTGCAATAATGGCTGCAGCTAGACATCAGTG TTCTTACTTAATAAACATGCATGTGGATGAATTTTTAAAGACTGGAGGTATTGCTGAGTGGTTGAATGGTTTGGAATATGTGCCACAAAGACTGAAAAATCTTAATGAAATTAATAAGCTGCTAGCAC ATCGACCTTGGCTGATCACAAAAGAGCACATTCAGAAACTTGTCAAAACTGGAGAAAATAATTGGTCTCTGCCTGAACTGGTACATGCTGTGGTCCTCCTGGCACATTATCATGCTTTGGCAAGCTTT GTTTTTGGTAGTGGTATCAATCCAGAGAGAGATCCAGAAATCTCCAATGGATTCAGGCTAATATCAGTCAACAATTTCTGCGTTTGTGATCTTGCTAATGACAACAACATAGAGAATGCATCTCTTTC AGGCAGCAACTTTGGGATTGTGGATTCTCTAAGTGAGCTAGAGGCCTTAATGGAAAGGATGAAAAGACTTCAAGAAGAAAGGGAAGATGAAGAGGCGTCTCAAGAAGAAATGAGCACTCGTTTTGAAA AGGAGAAGAAAGAAAGTCTTTTTGTGGTCTCTGGAGATACTTTTCATTCATTTCCTCATTCAGATTTTGAGGATGACATGATTATAACATCTGATGTCTCTCGATATATTGAAGACCCTGGTTTTGGG TATGAAGACTTTGCCAGACGAGGAGAAGAGCATTTGCCAACATTCCGAGCTCAGGACTATACCTGGGAAAATCATGGGTTCTCCCTGGTGAACAGACTTTATTCTGACATTGGACATCTTCTTGATGA AAAGTTTCGGATGGTCTACAATCTCACATATAACACTATGGCCACCCATGAGGATGTTGACACAACCATGCTGCGCAGAGCTTTATTTAACTATGTTCACTGTATGTTTGGAATCAGGTATGATGACT ATGATTATGGAGAAGTTAATCAATTACTTGAAAGAAGCCTGAAGGTTTACATTAAGACAGTGACCTGCTATCCTGAGAGAACTACAAAACGCATGTATGATAGTTACTGGCGGCAGTTCAAACACTCA GAAAAAGTTCATGTCAATCTACTTTTAATGGAAGCACGAATGCAAGCTGAACTTCTTTATGCTCTTCGTGCCATAACTCGGCATTTGACCTGAAGTATCACCCAAGGAAAATGTCATACATGTGTAAA GACCTTTCACATAAGATAAACATTGAAGCTATTTGTGATATAGCATCAAAAATTATTCAGTTCTCTAGTGTCAAAGTTTAGCCGTTTGTTTTTTTTTTTTTGTTTTTTGCGGCTGTAATGTGCAATGA TGTGTTTTATTTTCCTTGATGCTTAACATTACTAACAATTGCAAAAATAATACTGAGGAGCACTACTTTGCATTGTTTGTAGTTGGAGTTTTGGATACTGATCATAAATCATGAATCTGGCGTATTAA TGCTTAACTTCAGCGCCTTTGGGTTGTGTGTATGTGTATTTTTTCTCCCCCCACCCCGCCCTTTTTTTTTTAAGAATAAGGACAAGTGCTTACAATCTGCTCAAGCAATTGTTTTTCAGATATTGGAA TTCAGCAAAGAGTGACCTCTCTGGCCATTCTAAAACTTTAATGTTGTGTCCTAAATCTGGTGGAGGAAAAGCATGCGCTGTTGAACCAAGCTGCTCACTGGACACATATTTGTGTCCCCAGGAGATTA TTTGTCAGGCACTGTTTTTTATTTGTTTGTTTGTTCATTTATTGTTGTTTTACTGCTATTGGCGATAACATGAAATGTGATACAGCTATTGCCCATAATTTAATGTGAAATTAATCATGATGAATTCT ATAGCATGCTACTGAAATGCCAAATTCAGCTATTTTCTTTCTCTTCTAAAATGGAAGTTTCAGTTTTCCATATCAGATGTATATAAGTGGAATTATAACACAATCCTATCACTGACAGTAATCCTCAG TCACCTTAAATAATCAGTGCTCACAGTGCTGCTTACAGTTCATTTAGTTGGCACATATAAACCTGTACCCACACAAGACTGACCAAAAATTTTCTTTGCACATTTTTCCTTTCTCATAGTTTTTTTCT ATATTTCGTTAAGCAAAGGAAGGTTAATATGCCTATTTTTCCTGTTAGGCTTTTAGAAATTATTTTCCATGACTTTTGTTCTTATAATAGGTTAGACAGTTTATTTTTCAAAGGTAAAAATTGTGTTT CTATGCATTAATGTGATTGAACTACAAAAACAGAGTGCAATATGTTCAAAAAATACTCAACTAAACTTTCCCCCTGTCATATCACTGCAAAAGTGTCCTTTTAAACAGAGCCATAAAGAAATTTTTTT CAAATTTCTTTATTGCACAGGCTTTTTTCAGTTTTACCTTTCTGGGATTGAACAATGTTCCTTTCATAATGCCAAAGCATTCCCTTCCCCAGAAAAATCTCCTTGGACAACTGGTTTAAAAACGTTAT TAAGTCATAGGGGAGGAATAAGCGGCCAAAAAGTCACATTTTTGCATTGGTTTACGTTGCTTGATTAGACTATCTTCAGAGAGCACATTATGTGTTTATAGCTTTAATTTGTATTATGTCAATGAACC AGTGAAGTGCCTAAAGAGATGCTTACAACTATCCAGTAGGACACAACTGCACTGCTTTTTAAACACTTTTTGGTTAGTTAAGGGTGACTTGAATTGTACACATACATGCTAATTTTTGAAAACTTATC CATTTTTCATAGTAAATAATATAGATAAAATTTTCTGTTAGAGTTCCCGCAAATATTTCATTTTAGACTTACTTGTGATATAAGATTTAACTTTTCTTTTGTGAAAGAATCGTGAACTAGTGTTTCAT GAAATCATTTTCCTCTTCCATTTATCATCCTCCTCTGGTACAATATATTGGGTTGCTTTCTTTTAGATTTTGTTCCAGATAGGAAAACAAATATGACTGTATACTTATTAACATAAGGTAGTTCTGCA TTTTTGGATTCCAGGATCCTGTTTGAAATCTTCCATGTGAGGAAAAAATTACTAATATTTTTAAAGACAGGGTGGTTTATTTAAAGAGATTATTCAGAGAACTTGTGCCATATCTCGTCTGTTTTATT GCATATGCCATATGTTAACTTTTATTCAATATTACATTATGTAGATATGTAATACAAAGAAAATATTTAGGAGAATGGCAAAACACAAATGGCAACATAAATGTCCATTTGACTTACCTAACTTCACA ACTTTCAAGTTGAGGATGTCATTTATTCTTGAATTTGTTTTTTTACTAGATGCTTTCAATTAATAGCCCTATATTTTTGTGCAGGCGAACTGTATAACAGGATAAAAAATGATTTGTATGTATTGAAA AGGAGGAGAAATTCTCACAGAACACCATATGAGCTTTAGACCAAAAGGGGAAACAAGGTTTAAGTAACTAAAATGGCCACTTAGTTTGTGTTTATTTTTTTCCCTGGAAATGTAAGTAGTTGGAGTTT AGGCTATGGAAATATTAGTGCCTTTAATAGATCTCTTTCCTTGCAAAGTTTCTTTTTAGCTCAGCATTGATCTATCTTATCAATAGGAAAATAAGTTGACTTGGAACTATAAACAAAAACAACACCAT ATATTTATGAACCTCAGTGAACCAGCCTAGAAAAATTGACTTCTGCAGGTGCTAAAGCACCTACTAATACGCAGCATGCACAGCATTTCAGGTTGTGAATACCATTTTACAACGAGTTTGCTGTTAAC TCTCTTTATCCAATGCAAACTTGAAATTCTGATGCGGTTTTCCAGGGTGGTATTTTTTCAGAGTATTGAATTTACTATTTAGTAATTTATAGTATAGCTTTTTATATTAAAATGTGATATTTTTAAAA GAGATATCTGGTTCAATTGGTATAATGACGTGATTATGCAATATGCTGATCTACACCTTGCGCTCACATTGTGCCAAACTTAAATGTGCAAGTGTACGTGAGAAAAGCACATGTGAATGTGAATTCTT TAATTCTTTGCTTATTATGTTAAAATTAGTCTTCATAGTCCACTGATGTGTATGCTTGAATAATGTCTATTTACTTTGGAATTTCAAGATTTCCAGCTTCAATGGTAATTTATAATTTCTCAGATCAC CTTAAGAAATATTGAGATACTCTCCCACCTGAAAATAATCTGTTCTTTAACCCACCTGACTATGGGAGTAGCCAGGCAGGTGCCTCACTGGCTTCTTCAGACGAGGCTTCCTCAGGTGGATATATGAC TATTAGGGGAAAAGAGGCTTTTGAGACAGCTTATTACCTCCTTCCCCTTTTTGAACTAAGTACATTGTCTCAGTCCCAGTATGAATTTGTCCCATTTGGGGTATTTTTAAAATAAAAGATGGCTAACA TGGAATCTGGGGCATAGCCTTGGCCTTTAATTATGGTTGTAAGCCCAAATAATGGCAGAGAAACACAGGGCTGTTTTTACAACAGAAAACTCAATATAAGTTTTATATAAGAATCCTATAAAATTTGA ACCAGAGCTCCTATTTAGTTGTTATAATGTCTCCTAAAGATCTTAAATGCTTCTAAAAGCTAATTATTATTCCAGAGCAACTTTTTCCTTTTCCCCCTTATAAAGTTTTTTTTTAAATCCAAAATCTT AGATTTCTGTGCCACAGCAAAATAAAATGATCAACAATTAAAGATCTGTACTTAAAATAGTACACCATTTTTAGTGGAGGGAGGGTGCATGCCTATATGATGGTAAGATTCTTTTGAACTCTAAGGAC AATTCCTCATGGAAAAAATAAATTTCAGTGCATATTATAAAAATGATTTGCACTGTGTTAGCAAAATAAGGTGTTTTAGGTTGTATTTTAAAGACAATTCTAAATCATTTCTCTGGAAAGCAAGACCT TAAATTCTTCTCTTTAATAGAACTGCTTTTATGCAAAGAGATGGTCTTAACATGGACTAAACAGTACATAACAATAATGTTTGTTATGTAAATAGTATATCACATTTGCTTAGTAGCACAATTCAACA GCAGGCTGAAAGTCGTGGCTCCTCTGCTCAGATTGAGTTTTAAGTTACCTAATTTATGTAATCAGAATCTATTCTAGGTGGCCGTCAACGTAAACTGTGTTTCCCTATTATATCCCTCTGGAGACTGA GAATCAAATTAAATAGTCTTTCTTCAAAGCAGTACTGTAACATGAATGTATTTATCTCAGTCAACAGAACTTATATGCCCACTGTATGTGGAGCTTATTTCAATGCTAATTTGGCTTAGTTAGCAGAC CTAGAATCTGCCCAGGTGAGACCTAGAACAAAAATAGCTGGGGTGAAATGGATAAGAGAGGTAGAGGTATATGTCAAGGCAGAGCCCTATGAGGAAGGAAGAGTTTTCAAAGAATATGAGGAACATAG TGCTGAGAGTGTGGCTGCCTTCAGCACCGTACACCTAATCTAGAGAAAATATTTCCCATGTGGGAGGTCCTGTCTGCATTCAGTCCACCCTTTTCTGCCTGCTTCTTCCTCCAAGTGCCTCAACCTCT ACATGCTCACTCTCCTCCCCTTCCCTCAGCCCATCTTGGTCTAAGCAGCTTTCACAATCCAAACCAAACATCACCAGCCACCCGCTGATAAGTCACCAGCATTTACTTTCCTGAGTTACTTTTTCTCC ATTCATTGAGACTATGGATTCATCCCAACTCCTTCTAAATCCCTCAACCATCCAGCTATATTTTGGCTAACCTTTGCCCTAGACACTCTACCAGATGTTAATGCAGTATCAAGTGTAAATTGTGTCAC CCTATTCTGTTCTACCCTTTTCCCTGCTGCCGAAATATCTTGCTCTCCTCTACCTCATCCCCAAAGAGCCTATAAATTCAGAGTATCCAACCTTTTCATGGATTCACTCACTGTTGTTCAGTAATACA ACTTCCATATTTTAAATAAATCATAAAAGATTTTTGCCTTCTATCAAAGTAGGAAACTTTATATTTATACATGATACAGAAATTGAACTATTTCTATCGTTCAGAATTTAGCATATAACAGGATTTTA AAGTGATTGAATTGCCATCCTAACTTGGATTTGTATTAGGTTATGAATGAATACTGTTGTTAGTCCAAGCTATTTGAATGTAAAGTTAAAATTCTCCAGCAATCCAGAATGACTTGTAACCCTTCAGT GGAATGGGAAATTTCTGGTATGCAAATAGGGTGGTGTTCCAGACATTTGTTTTATTGGTGGTGTTTGGGCCTTGAAACACATTTCTAATAGAATGACATATGGCAAAGGGTATTTAGATGGTCCTATG GGATCACAGAAGCCCATATGATTTAAAATATAGATAAAATAACACAAAATTGGGTACATAAGGGTTTAACCAGGCTTTCCTGGGTTAGACTAAGCCTCTAACCTCTGTTCCTATCCTGTTCTTATGGG AGGAAAAAAAATGTTCCATGGGATGAAAAGAAAATGCATTGACTTTGTAGTCTTTATTCTCCTAGCCGCACTTCGGGTATATCCAGAAGGAAGAGGAAATGCAAAGAGGAAGAAGATGTAATAGTTCT TCTCTCCAGCTAGGTGCACTTGAGGTTGTTCATAAATGTAAAATTATGTCAGGTTTCTAACATGGGACACTGCACACAGTTGTCTGACCTGATGAACCATCCCATTTGAAAGTATAGATTATTATTAT TTCTTGTAGTATTTGGTTGTTTTCCATCTCATTCATGAACAACTCAACCTGATAGTAGTATCCAATAAATGCCTTTCAGGGCTCAGGAATGAATTGACATCCTAGTTAAGAAATGAGACTTAATAATG GAGACTGAATGAGGCGGTTTGTATTAAATTATATGCCATGAAGTGTTCATTTTAGCTTTAACCTAATTATGACTGTACCACCATGAAGTACAGAATGAAAAATTATATATATGGGGGGGAAACAGAAT GAATATCTGATTCTTTTGAATGCTTGTGGAAATCTTTGAGATCGTGCAGGGCATACCACAAAATAGCCTTTAGAACAGATACCCAATTTTACAGTTCATAGGACAACATCAAACATTAGTAAGTCTAA ATAAGATGAATAGAATTTTTGTTATGTAAATTTTGCTAGAACAGTCTATTTTCTTGCACCCCTCAAGTTAACCTCTTAAAAAAATGAATGTATAATTTCTACCGAAAGAATATCAGAGAGAATCTCTC TGGCCTATAGTGTTAAAATATTGTTCACAAATCCTGATTAGTTAAGTGCATACATTATGAAACTTACAGAATAAAACTTATTATACATCTCTTTCTTAAATTAATATCTTTACACATTTTCAACTGGC TCCCCAAGTCTGATAAGGAAGGATTAAAAGAAAAAAGAAATGTATTAGTTGGGTGGCCAAGGAGTTTCCTTTGTAATGTTGAGAGACTTCCGCTTTCTGAATTTCGCTGGTTCTCTAAGGTAAAAGAG TTAAATAGTACCCTTGTTCACCAAGGAAAGTGATCCAAACTATATATCTAGTGCAGATATTTCCTTTGCATTATTTAGTCTTCTCTGGAGAGAAAATACAGTTTCCCCTTCCTCTTTCTCTTCACATT TACTCTTTTCAACCCAAAATAAGAGACATAGAAAGCAAACCACAGCCAGTTTGGCATCTTCTCAGTGCTACTAGTATAGGCACATACACATACACAGTCTCAGCAAGGTTATAAAGAACCCTGTCAGG TCCACTTGCAACATGGCCTTGCTACTTGGATTAGCTCCTTTAAGCCTGAAAATAACTTTCCTGGTCATGGAAGAACTGGACGCATCTTTTAACTTATGAAATAGAAGTTGAACTTGAAAACTCTTTTT AAAAAATCCTGGTTTTGCAGGACAGCTACATAATGAATGTATATATTAAGACTGTAGCTGAATTGCACATGAAATCAGATTGCCAACTTCTTGACTTTCAATGTTAGACATTTATCCTTAAGTTGTGA GCGATATATGTAGCATGCTGTGAAATGTCTGTTATAGCTCTTTAATTCATCAGTATTAATACAGAATTATCATTTGCGTTTCTTGGTACTTTTTATTCAATGTAATCAGAAGCTGTGATGTTTTGCCT TTGTAGTCCTGTGCTTTGTTACTGTAATTTTTTTTTTTTTTTTACGAAGCACGTGACTGGACTAATGTAAGGCAGATGACGTGATCTTTAAGACTGCTATATATATCAGTCTCTTACTCTATAAGGTT TTAAATTAGAATAAGCTTTTATCAAATAGATAATTGATGCAATTTAGGATTCACGCAAGTTTCAGTGTCAAATGGCGGTCTTATAGTTTCAATTCTGAAAATAGCAAACTTAATAAACAGCCACTTTA AACTTGTTCTGGCAAACCAGACCCTGCTGTAGATATAGTCTAAGGTAGTTAACCATATAAGCCTTTTCAACTCTTAATGCCCTCCACATGAATCAGCAGTTAAGAAGGTTCTAGAACCCATGAAAGCT TTTGTATGTATTACTAGGTTTTGTTTTTCTTATGTTTGCTGATTTTACAGTTCTGACTAAAGCTGACCTAAATGGATCAGTTTATGTGTAATATTCTAGTGCTTTAATGACTCTTTTTTTCTTTGGAG GGAGGGTAACATTATTTGGACAGATGCAGAAGGAACTGTTAGTGAGTCAAGACAAACACATCTGAAATAAAGGAACTGTGTATTAACATGTTAACAATTCATAACTGCACTTTTTATGACATTTTGAA AATCTATTTATAGGTACAGAACAATGGGTTTTGTTAAACTGTATCACATTTATACTTGCAGAAATTTATTTCATTGTTATTAGTAGGAATTTTATTGGTTCAATAAAATTGGCAAAACTGAACACCAA TCATTTGCCTACTTTGTTTATACTGGA
hide sequence
RefSeq Acc Id:
XM_011542614 ⟹ XP_011540916
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 11 95,165,513 - 95,232,475 (-) NCBI
Sequence:
ATAATGCACAGTCCTGTGGCCACGGCCATGGCCGGGTGGGGAGCTGGGCTCCAGTGAGCACAGA GCTCCTTGCCAGTAGGCGATGCAAGTTATCTCTGGGGCCCGGAGGACACGAGTGAGGACCGGGCACCAATCAGGTTCTCGCTCTGCGCCGGCCTTTGTTCTCACTCGGGAGCAGGTTGCGGGCGTCTA GCATCGGGAACCCGCATTCGACTCGGACGCGCATTGCTAGCCCCTTCGGGAGACCTGGCTCCCCTACCCGTCTGTCCCGCCACACTCGGTCAGCCTGCGCTTTCCCCAGTCAAGTCTGCCTTCTCTCC GCAGAACGTGGACGCTAAAACCCTGACTTACCATTTTAAGCTTTAGAAGAGCCAAGAGCAGCCAATTAGAGCATAATGGACAAGGATAAAAGAATCAGAGTGTCTCAACCCTTGACAAGAGGACCAAG TGCCTTTATTCCAGAGAAGGAAGTTGTCCAAGCAAACACAGTGGATGAACGTACTAACTTTCTTGTGGAAGAATACTCTACATCCGGTCGTCTGGACAACATCACACAGGTCATGAGTTTACACACTC AGTACCTGGAGTCTTTCTTGCGGAGCCAGTTTTACATGTTGCGCATGGATGGTCCCCTTCCTCTACCATACAGGCACTATATTGCAATAATGGCTGCAGCTAGACATCAGTGTTCTTACTTAATAAAC ATGCATGTGGATGAATTTTTAAAGACTGGAGGTATTGCTGAGTGGTTGAATGGTTTGGAATATGTGCCACAAAGACTGAAAAATCTTAATGAAATTAATAAGCTGCTAGCACATCGACCTTGGCTGAT CACAAAAGAGCACATTCAGAAACTTGTCAAAACTGGAGAAAATAATTGGTCTCTGCCTGAACTGGTACATGCTGTGGTCCTCCTGGCACATTATCATGCTTTGGCAAGCTTTGTTTTTGGTAGTGGTA TCAATCCAGAGAGAGATCCAGAAATCTCCAATGGATTCAGGCTAATATCAGTCAACAATTTCTGCGTTTGTGATCTTGCTAATGACAACAACATAGAGAATGCATCTCTTTCAGGCAGCAACTTTGGG ATTGTGGATTCTCTAAGTGAGCTAGAGGCCTTAATGGAAAGGATGAAAAGACTTCAAGAAGAAAGGGAAGATGAAGAGGCGTCTCAAGAAGAAATGAGCACTCGTTTTGAAAAGGAGAAGAAAGAAAG TCTTTTTGTGGTCTCTGGAGATACTTTTCATTCATTTCCTCATTCAGATTTTGAGGATGACATGATTATAACATCTGATGTCTCTCGATATATTGAAGACCCTGGTTTTGGGTATGAAGACTTTGCCA GACGAGGAGAAGAGCATTTGCCAACATTCCGAGCTCAGGACTATACCTGGGAAAATCATGGGTTCTCCCTGGTGAACAGACTTTATTCTGACATTGGACATCTTCTTGATGAAAAGTTTCGGATGGTC TACAATCTCACATATAACACTATGGCCACCCATGAGGATGTTGACACAACCATGCTGCGCAGAGCTTTATTTAACTATGTTCACTGTATGTTTGGAATCAGGTATGATGACTATGATTATGGAGAAGT TAATCAATTACTTGAAAGAAGCCTGAAGGTTTACATTAAGACAGTGACCTGCTATCCTGAGAGAACTACAAAACGCATGTATGATAGTTACTGGCGGCAGTTCAAACACTCAGAAAAAGTTCATGTCA ATCTACTTTTAATGGAAGCACGAATGCAAGCTGAACTTCTTTATGCTCTTCGTGCCATAACTCGGCATTTGACCTGAAGTATCACCCAAGGAAAATGTCATACATGTGTAAAGACCTTTCACATAAGA TAAACATTGAAGCTATTTGTGATATAGCATCAAAAATTATTCAGTTCTCTAGTGTCAAAGTTTAGCCGTTTGTTTTTTTTTTTTTGTTTTTTGCGGCTGTAATGTGCAATGATGTGTTTTATTTTCCT TGATGCTTAACATTACTAACAATTGCAAAAATAATACTGAGGAGCACTACTTTGCATTGTTTGTAGTTGGAGTTTTGGATACTGATCATAAATCATGAATCTGGCGTATTAATGCTTAACTTCAGCGC CTTTGGGTTGTGTGTATGTGTATTTTTTCTCCCCCCACCCCGCCCTTTTTTTTTTAAGAATAAGGACAAGTGCTTACAATCTGCTCAAGCAATTGTTTTTCAGATATTGGAATTCAGCAAAGAGTGAC CTCTCTGGCCATTCTAAAACTTTAATGTTGTGTCCTAAATCTGGTGGAGGAAAAGCATGCGCTGTTGAACCAAGCTGCTCACTGGACACATATTTGTGTCCCCAGGAGATTATTTGTCAGGCACTGTT TTTTATTTGTTTGTTTGTTCATTTATTGTTGTTTTACTGCTATTGGCGATAACATGAAATGTGATACAGCTATTGCCCATAATTTAATGTGAAATTAATCATGATGAATTCTATAGCATGCTACTGAA ATGCCAAATTCAGCTATTTTCTTTCTCTTCTAAAATGGAAGTTTCAGTTTTCCATATCAGATGTATATAAGTGGAATTATAACACAATCCTATCACTGACAGTAATCCTCAGTCACCTTAAATAATCA GTGCTCACAGTGCTGCTTACAGTTCATTTAGTTGGCACATATAAACCTGTACCCACACAAGACTGACCAAAAATTTTCTTTGCACATTTTTCCTTTCTCATAGTTTTTTTCTATATTTCGTTAAGCAA AGGAAGGTTAATATGCCTATTTTTCCTGTTAGGCTTTTAGAAATTATTTTCCATGACTTTTGTTCTTATAATAGGTTAGACAGTTTATTTTTCAAAGGTAAAAATTGTGTTTCTATGCATTAATGTGA TTGAACTACAAAAACAGAGTGCAATATGTTCAAAAAATACTCAACTAAACTTTCCCCCTGTCATATCACTGCAAAAGTGTCCTTTTAAACAGAGCCATAAAGAAATTTTTTTCAAATTTCTTTATTGC ACAGGCTTTTTTCAGTTTTACCTTTCTGGGATTGAACAATGTTCCTTTCATAATGCCAAAGCATTCCCTTCCCCAGAAAAATCTCCTTGGACAACTGGTTTAAAAACGTTATTAAGTCATAGGGGAGG AATAAGCGGCCAAAAAGTCACATTTTTGCATTGGTTTACGTTGCTTGATTAGACTATCTTCAGAGAGCACATTATGTGTTTATAGCTTTAATTTGTATTATGTCAATGAACCAGTGAAGTGCCTAAAG AGATGCTTACAACTATCCAGTAGGACACAACTGCACTGCTTTTTAAACACTTTTTGGTTAGTTAAGGGTGACTTGAATTGTACACATACATGCTAATTTTTGAAAACTTATCCATTTTTCATAGTAAA TAATATAGATAAAATTTTCTGTTAGAGTTCCCGCAAATATTTCATTTTAGACTTACTTGTGATATAAGATTTAACTTTTCTTTTGTGAAAGAATCGTGAACTAGTGTTTCATGAAATCATTTTCCTCT TCCATTTATCATCCTCCTCTGGTACAATATATTGGGTTGCTTTCTTTTAGATTTTGTTCCAGATAGGAAAACAAATATGACTGTATACTTATTAACATAAGGTAGTTCTGCATTTTTGGATTCCAGGA TCCTGTTTGAAATCTTCCATGTGAGGAAAAAATTACTAATATTTTTAAAGACAGGGTGGTTTATTTAAAGAGATTATTCAGAGAACTTGTGCCATATCTCGTCTGTTTTATTGCATATGCCATATGTT AACTTTTATTCAATATTACATTATGTAGATATGTAATACAAAGAAAATATTTAGGAGAATGGCAAAACACAAATGGCAACATAAATGTCCATTTGACTTACCTAACTTCACAACTTTCAAGTTGAGGA TGTCATTTATTCTTGAATTTGTTTTTTTACTAGATGCTTTCAATTAATAGCCCTATATTTTTGTGCAGGCGAACTGTATAACAGGATAAAAAATGATTTGTATGTATTGAAAAGGAGGAGAAATTCTC ACAGAACACCATATGAGCTTTAGACCAAAAGGGGAAACAAGGTTTAAGTAACTAAAATGGCCACTTAGTTTGTGTTTATTTTTTTCCCTGGAAATGTAAGTAGTTGGAGTTTAGGCTATGGAAATATT AGTGCCTTTAATAGATCTCTTTCCTTGCAAAGTTTCTTTTTAGCTCAGCATTGATCTATCTTATCAATAGGAAAATAAGTTGACTTGGAACTATAAACAAAAACAACACCATATATTTATGAACCTCA GTGAACCAGCCTAGAAAAATTGACTTCTGCAGGTGCTAAAGCACCTACTAATACGCAGCATGCACAGCATTTCAGGTTGTGAATACCATTTTACAACGAGTTTGCTGTTAACTCTCTTTATCCAATGC AAACTTGAAATTCTGATGCGGTTTTCCAGGGTGGTATTTTTTCAGAGTATTGAATTTACTATTTAGTAATTTATAGTATAGCTTTTTATATTAAAATGTGATATTTTTAAAAGAGATATCTGGTTCAA TTGGTATAATGACGTGATTATGCAATATGCTGATCTACACCTTGCGCTCACATTGTGCCAAACTTAAATGTGCAAGTGTACGTGAGAAAAGCACATGTGAATGTGAATTCTTTAATTCTTTGCTTATT ATGTTAAAATTAGTCTTCATAGTCCACTGATGTGTATGCTTGAATAATGTCTATTTACTTTGGAATTTCAAGATTTCCAGCTTCAATGGTAATTTATAATTTCTCAGATCACCTTAAGAAATATTGAG ATACTCTCCCACCTGAAAATAATCTGTTCTTTAACCCACCTGACTATGGGAGTAGCCAGGCAGGTGCCTCACTGGCTTCTTCAGACGAGGCTTCCTCAGGTGGATATATGACTATTAGGGGAAAAGAG GCTTTTGAGACAGCTTATTACCTCCTTCCCCTTTTTGAACTAAGTACATTGTCTCAGTCCCAGTATGAATTTGTCCCATTTGGGGTATTTTTAAAATAAAAGATGGCTAACATGGAATCTGGGGCATA GCCTTGGCCTTTAATTATGGTTGTAAGCCCAAATAATGGCAGAGAAACACAGGGCTGTTTTTACAACAGAAAACTCAATATAAGTTTTATATAAGAATCCTATAAAATTTGAACCAGAGCTCCTATTT AGTTGTTATAATGTCTCCTAAAGATCTTAAATGCTTCTAAAAGCTAATTATTATTCCAGAGCAACTTTTTCCTTTTCCCCCTTATAAAGTTTTTTTTTAAATCCAAAATCTTAGATTTCTGTGCCACA GCAAAATAAAATGATCAACAATTAAAGATCTGTACTTAAAATAGTACACCATTTTTAGTGGAGGGAGGGTGCATGCCTATATGATGGTAAGATTCTTTTGAACTCTAAGGACAATTCCTCATGGAAAA AATAAATTTCAGTGCATATTATAAAAATGATTTGCACTGTGTTAGCAAAATAAGGTGTTTTAGGTTGTATTTTAAAGACAATTCTAAATCATTTCTCTGGAAAGCAAGACCTTAAATTCTTCTCTTTA ATAGAACTGCTTTTATGCAAAGAGATGGTCTTAACATGGACTAAACAGTACATAACAATAATGTTTGTTATGTAAATAGTATATCACATTTGCTTAGTAGCACAATTCAACAGCAGGCTGAAAGTCGT GGCTCCTCTGCTCAGATTGAGTTTTAAGTTACCTAATTTATGTAATCAGAATCTATTCTAGGTGGCCGTCAACGTAAACTGTGTTTCCCTATTATATCCCTCTGGAGACTGAGAATCAAATTAAATAG TCTTTCTTCAAAGCAGTACTGTAACATGAATGTATTTATCTCAGTCAACAGAACTTATATGCCCACTGTATGTGGAGCTTATTTCAATGCTAATTTGGCTTAGTTAGCAGACCTAGAATCTGCCCAGG TGAGACCTAGAACAAAAATAGCTGGGGTGAAATGGATAAGAGAGGTAGAGGTATATGTCAAGGCAGAGCCCTATGAGGAAGGAAGAGTTTTCAAAGAATATGAGGAACATAGTGCTGAGAGTGTGGCT GCCTTCAGCACCGTACACCTAATCTAGAGAAAATATTTCCCATGTGGGAGGTCCTGTCTGCATTCAGTCCACCCTTTTCTGCCTGCTTCTTCCTCCAAGTGCCTCAACCTCTACATGCTCACTCTCCT CCCCTTCCCTCAGCCCATCTTGGTCTAAGCAGCTTTCACAATCCAAACCAAACATCACCAGCCACCCGCTGATAAGTCACCAGCATTTACTTTCCTGAGTTACTTTTTCTCCATTCATTGAGACTATG GATTCATCCCAACTCCTTCTAAATCCCTCAACCATCCAGCTATATTTTGGCTAACCTTTGCCCTAGACACTCTACCAGATGTTAATGCAGTATCAAGTGTAAATTGTGTCACCCTATTCTGTTCTACC CTTTTCCCTGCTGCCGAAATATCTTGCTCTCCTCTACCTCATCCCCAAAGAGCCTATAAATTCAGAGTATCCAACCTTTTCATGGATTCACTCACTGTTGTTCAGTAATACAACTTCCATATTTTAAA TAAATCATAAAAGATTTTTGCCTTCTATCAAAGTAGGAAACTTTATATTTATACATGATACAGAAATTGAACTATTTCTATCGTTCAGAATTTAGCATATAACAGGATTTTAAAGTGATTGAATTGCC ATCCTAACTTGGATTTGTATTAGGTTATGAATGAATACTGTTGTTAGTCCAAGCTATTTGAATGTAAAGTTAAAATTCTCCAGCAATCCAGAATGACTTGTAACCCTTCAGTGGAATGGGAAATTTCT GGTATGCAAATAGGGTGGTGTTCCAGACATTTGTTTTATTGGTGGTGTTTGGGCCTTGAAACACATTTCTAATAGAATGACATATGGCAAAGGGTATTTAGATGGTCCTATGGGATCACAGAAGCCCA TATGATTTAAAATATAGATAAAATAACACAAAATTGGGTACATAAGGGTTTAACCAGGCTTTCCTGGGTTAGACTAAGCCTCTAACCTCTGTTCCTATCCTGTTCTTATGGGAGGAAAAAAAATGTTC CATGGGATGAAAAGAAAATGCATTGACTTTGTAGTCTTTATTCTCCTAGCCGCACTTCGGGTATATCCAGAAGGAAGAGGAAATGCAAAGAGGAAGAAGATGTAATAGTTCTTCTCTCCAGCTAGGTG CACTTGAGGTTGTTCATAAATGTAAAATTATGTCAGGTTTCTAACATGGGACACTGCACACAGTTGTCTGACCTGATGAACCATCCCATTTGAAAGTATAGATTATTATTATTTCTTGTAGTATTTGG TTGTTTTCCATCTCATTCATGAACAACTCAACCTGATAGTAGTATCCAATAAATGCCTTTCAGGGCTCAGGAATGAATTGACATCCTAGTTAAGAAATGAGACTTAATAATGGAGACTGAATGAGGCG GTTTGTATTAAATTATATGCCATGAAGTGTTCATTTTAGCTTTAACCTAATTATGACTGTACCACCATGAAGTACAGAATGAAAAATTATATATATGGGGGGGAAACAGAATGAATATCTGATTCTTT TGAATGCTTGTGGAAATCTTTGAGATCGTGCAGGGCATACCACAAAATAGCCTTTAGAACAGATACCCAATTTTACAGTTCATAGGACAACATCAAACATTAGTAAGTCTAAATAAGATGAATAGAAT TTTTGTTATGTAAATTTTGCTAGAACAGTCTATTTTCTTGCACCCCTCAAGTTAACCTCTTAAAAAAATGAATGTATAATTTCTACCGAAAGAATATCAGAGAGAATCTCTCTGGCCTATAGTGTTAA AATATTGTTCACAAATCCTGATTAGTTAAGTGCATACATTATGAAACTTACAGAATAAAACTTATTATACATCTCTTTCTTAAATTAATATCTTTACACATTTTCAACTGGCTCCCCAAGTCTGATAA GGAAGGATTAAAAGAAAAAAGAAATGTATTAGTTGGGTGGCCAAGGAGTTTCCTTTGTAATGTTGAGAGACTTCCGCTTTCTGAATTTCGCTGGTTCTCTAAGGTAAAAGAGTTAAATAGTACCCTTG TTCACCAAGGAAAGTGATCCAAACTATATATCTAGTGCAGATATTTCCTTTGCATTATTTAGTCTTCTCTGGAGAGAAAATACAGTTTCCCCTTCCTCTTTCTCTTCACATTTACTCTTTTCAACCCA AAATAAGAGACATAGAAAGCAAACCACAGCCAGTTTGGCATCTTCTCAGTGCTACTAGTATAGGCACATACACATACACAGTCTCAGCAAGGTTATAAAGAACCCTGTCAGGTCCACTTGCAACATGG CCTTGCTACTTGGATTAGCTCCTTTAAGCCTGAAAATAACTTTCCTGGTCATGGAAGAACTGGACGCATCTTTTAACTTATGAAATAGAAGTTGAACTTGAAAACTCTTTTTAAAAAATCCTGGTTTT GCAGGACAGCTACATAATGAATGTATATATTAAGACTGTAGCTGAATTGCACATGAAATCAGATTGCCAACTTCTTGACTTTCAATGTTAGACATTTATCCTTAAGTTGTGAGCGATATATGTAGCAT GCTGTGAAATGTCTGTTATAGCTCTTTAATTCATCAGTATTAATACAGAATTATCATTTGCGTTTCTTGGTACTTTTTATTCAATGTAATCAGAAGCTGTGATGTTTTGCCTTTGTAGTCCTGTGCTT TGTTACTGTAATTTTTTTTTTTTTTTTACGAAGCACGTGACTGGACTAATGTAAGGCAGATGACGTGATCTTTAAGACTGCTATATATATCAGTCTCTTACTCTATAAGGTTTTAAATTAGAATAAGC TTTTATCAAATAGATAATTGATGCAATTTAGGATTCACGCAAGTTTCAGTGTCAAATGGCGGTCTTATAGTTTCAATTCTGAAAATAGCAAACTTAATAAACAGCCACTTTAAACTTGTTCTGGCAAA CCAGACCCTGCTGTAGATATAGTCTAAGGTAGTTAACCATATAAGCCTTTTCAACTCTTAATGCCCTCCACATGAATCAGCAGTTAAGAAGGTTCTAGAACCCATGAAAGCTTTTGTATGTATTACTA GGTTTTGTTTTTCTTATGTTTGCTGATTTTACAGTTCTGACTAAAGCTGACCTAAATGGATCAGTTTATGTGTAATATTCTAGTGCTTTAATGACTCTTTTTTTCTTTGGAGGGAGGGTAACATTATT TGGACAGATGCAGAAGGAACTGTTAGTGAGTCAAGACAAACACATCTGAAATAAAGGAACTGTGTATTAACATGTTAACAATTCATAACTGCACTTTTTATGACATTTTGAAAATCTATTTATAGGTA CAGAACAATGGGTTTTGTTAAACTGTATCACATTTATACTTGCAGAAATTTATTTCATTGTTATTAGTAGGAATTTTATTGGTTCAATAAAATTGGCAAAACTGAACACCAA
hide sequence
RefSeq Acc Id:
XM_024448355 ⟹ XP_024304123
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 11 95,165,513 - 95,232,337 (-) NCBI
Sequence:
GGTGATGTCATAATGCACAGTCCTGTGGCCACGGCCATGGCCGGGTGGGGAGCTGGGCTCCAGTGAGCACAGAGCTCCTTGCCAGTAGGCGATGCAAGTTATCTCTGGGGCCCGGAGGACACGAGTGA GGACCGGGCACCAATCAGGTTCTCGCTCTGCGCCGGCCTTTGTTCTCACTCGGGAGCAGGTTGCGGGCGTCTAGCATCGGGAACCCGCATTCGACTCGGACGCGCATTGCTAGCCCCTTCGGGAGACC TGGCTCCCCTACCCGTCTGTCCCGCCACACTCGGTCAGCCTGCGCTTTCCCCAGTCAAGTCTGCCTTCTCTCCGCAGAACGTGGACGCTAAAACCCTGACTTACCATTTTAAGCTTTAGAAGAGGATA AAAGAATCAGAGTGTCTCAACCCTTGACAAGAGGACCAAGTGCCTTTATTCCAGAGAAGGAAGTTGTCCAAGCAAACACAGTGGATGAACGTACTAACTTTCTTGTGGAAGAATACTCTACATCCGGT CGTCTGGACAACATCACACAGGTCATGAGTTTACACACTCAGTACCTGGAGTCTTTCTTGCGGAGCCAGTTTTACATGTTGCGCATGGATGGTCCCCTTCCTCTACCATACAGGCACTATATTGCAAT AATGGCTGCAGCTAGACATCAGTGTTCTTACTTAATAAACATGCATGTGGATGAATTTTTAAAGACTGGAGGTATTGCTGAGTGGTTGAATGGTTTGGAATATGTGCCACAAAGACTGAAAAATCTTA ATGAAATTAATAAGCTGCTAGCACATCGACCTTGGCTGATCACAAAAGAGCACATTCAGAAACTTGTCAAAACTGGAGAAAATAATTGGTCTCTGCCTGAACTGGTACATGCTGTGGTCCTCCTGGCA CATTATCATGCTTTGGCAAGCTTTGTTTTTGGTAGTGGTATCAATCCAGAGAGAGATCCAGAAATCTCCAATGGATTCAGGCTAATATCAGTCAACAATTTCTGCGTTTGTGATCTTGCTAATGACAA CAACATAGAGAATGCATCTCTTTCAGGCAGCAACTTTGGGATTGTGGATTCTCTAAGTGAGCTAGAGGCCTTAATGGAAAGGATGAAAAGACTTCAAGAAGAAAGGGAAGATGAAGAGGCGTCTCAAG AAGAAATGAGCACTCGTTTTGAAAAGGAGAAGAAAGAAAGTCTTTTTGTGGTCTCTGGAGATACTTTTCATTCATTTCCTCATTCAGATTTTGAGGATGACATGATTATAACATCTGATGTCTCTCGA TATATTGAAGACCCTGGTTTTGGGTATGAAGACTTTGCCAGACGAGGAGAAGAGCATTTGCCAACATTCCGAGCTCAGGACTATACCTGGGAAAATCATGGGTTCTCCCTGGTGAACAGACTTTATTC TGACATTGGACATCTTCTTGATGAAAAGTTTCGGATGGTCTACAATCTCACATATAACACTATGGCCACCCATGAGGATGTTGACACAACCATGCTGCGCAGAGCTTTATTTAACTATGTTCACTGTA TGTTTGGAATCAGGTATGATGACTATGATTATGGAGAAGTTAATCAATTACTTGAAAGAAGCCTGAAGGTTTACATTAAGACAGTGACCTGCTATCCTGAGAGAACTACAAAACGCATGTATGATAGT TACTGGCGGCAGTTCAAACACTCAGAAAAAGTTCATGTCAATCTACTTTTAATGGAAGCACGAATGCAAGCTGAACTTCTTTATGCTCTTCGTGCCATAACTCGGCATTTGACCTGAAGTATCACCCA AGGAAAATGTCATACATGTGTAAAGACCTTTCACATAAGATAAACATTGAAGCTATTTGTGATATAGCATCAAAAATTATTCAGTTCTCTAGTGTCAAAGTTTAGCCGTTTGTTTTTTTTTTTTTGTT TTTTGCGGCTGTAATGTGCAATGATGTGTTTTATTTTCCTTGATGCTTAACATTACTAACAATTGCAAAAATAATACTGAGGAGCACTACTTTGCATTGTTTGTAGTTGGAGTTTTGGATACTGATCA TAAATCATGAATCTGGCGTATTAATGCTTAACTTCAGCGCCTTTGGGTTGTGTGTATGTGTATTTTTTCTCCCCCCACCCCGCCCTTTTTTTTTTAAGAATAAGGACAAGTGCTTACAATCTGCTCAA GCAATTGTTTTTCAGATATTGGAATTCAGCAAAGAGTGACCTCTCTGGCCATTCTAAAACTTTAATGTTGTGTCCTAAATCTGGTGGAGGAAAAGCATGCGCTGTTGAACCAAGCTGCTCACTGGACA CATATTTGTGTCCCCAGGAGATTATTTGTCAGGCACTGTTTTTTATTTGTTTGTTTGTTCATTTATTGTTGTTTTACTGCTATTGGCGATAACATGAAATGTGATACAGCTATTGCCCATAATTTAAT GTGAAATTAATCATGATGAATTCTATAGCATGCTACTGAAATGCCAAATTCAGCTATTTTCTTTCTCTTCTAAAATGGAAGTTTCAGTTTTCCATATCAGATGTATATAAGTGGAATTATAACACAAT CCTATCACTGACAGTAATCCTCAGTCACCTTAAATAATCAGTGCTCACAGTGCTGCTTACAGTTCATTTAGTTGGCACATATAAACCTGTACCCACACAAGACTGACCAAAAATTTTCTTTGCACATT TTTCCTTTCTCATAGTTTTTTTCTATATTTCGTTAAGCAAAGGAAGGTTAATATGCCTATTTTTCCTGTTAGGCTTTTAGAAATTATTTTCCATGACTTTTGTTCTTATAATAGGTTAGACAGTTTAT TTTTCAAAGGTAAAAATTGTGTTTCTATGCATTAATGTGATTGAACTACAAAAACAGAGTGCAATATGTTCAAAAAATACTCAACTAAACTTTCCCCCTGTCATATCACTGCAAAAGTGTCCTTTTAA ACAGAGCCATAAAGAAATTTTTTTCAAATTTCTTTATTGCACAGGCTTTTTTCAGTTTTACCTTTCTGGGATTGAACAATGTTCCTTTCATAATGCCAAAGCATTCCCTTCCCCAGAAAAATCTCCTT GGACAACTGGTTTAAAAACGTTATTAAGTCATAGGGGAGGAATAAGCGGCCAAAAAGTCACATTTTTGCATTGGTTTACGTTGCTTGATTAGACTATCTTCAGAGAGCACATTATGTGTTTATAGCTT TAATTTGTATTATGTCAATGAACCAGTGAAGTGCCTAAAGAGATGCTTACAACTATCCAGTAGGACACAACTGCACTGCTTTTTAAACACTTTTTGGTTAGTTAAGGGTGACTTGAATTGTACACATA CATGCTAATTTTTGAAAACTTATCCATTTTTCATAGTAAATAATATAGATAAAATTTTCTGTTAGAGTTCCCGCAAATATTTCATTTTAGACTTACTTGTGATATAAGATTTAACTTTTCTTTTGTGA AAGAATCGTGAACTAGTGTTTCATGAAATCATTTTCCTCTTCCATTTATCATCCTCCTCTGGTACAATATATTGGGTTGCTTTCTTTTAGATTTTGTTCCAGATAGGAAAACAAATATGACTGTATAC TTATTAACATAAGGTAGTTCTGCATTTTTGGATTCCAGGATCCTGTTTGAAATCTTCCATGTGAGGAAAAAATTACTAATATTTTTAAAGACAGGGTGGTTTATTTAAAGAGATTATTCAGAGAACTT GTGCCATATCTCGTCTGTTTTATTGCATATGCCATATGTTAACTTTTATTCAATATTACATTATGTAGATATGTAATACAAAGAAAATATTTAGGAGAATGGCAAAACACAAATGGCAACATAAATGT CCATTTGACTTACCTAACTTCACAACTTTCAAGTTGAGGATGTCATTTATTCTTGAATTTGTTTTTTTACTAGATGCTTTCAATTAATAGCCCTATATTTTTGTGCAGGCGAACTGTATAACAGGATA AAAAATGATTTGTATGTATTGAAAAGGAGGAGAAATTCTCACAGAACACCATATGAGCTTTAGACCAAAAGGGGAAACAAGGTTTAAGTAACTAAAATGGCCACTTAGTTTGTGTTTATTTTTTTCCC TGGAAATGTAAGTAGTTGGAGTTTAGGCTATGGAAATATTAGTGCCTTTAATAGATCTCTTTCCTTGCAAAGTTTCTTTTTAGCTCAGCATTGATCTATCTTATCAATAGGAAAATAAGTTGACTTGG AACTATAAACAAAAACAACACCATATATTTATGAACCTCAGTGAACCAGCCTAGAAAAATTGACTTCTGCAGGTGCTAAAGCACCTACTAATACGCAGCATGCACAGCATTTCAGGTTGTGAATACCA TTTTACAACGAGTTTGCTGTTAACTCTCTTTATCCAATGCAAACTTGAAATTCTGATGCGGTTTTCCAGGGTGGTATTTTTTCAGAGTATTGAATTTACTATTTAGTAATTTATAGTATAGCTTTTTA TATTAAAATGTGATATTTTTAAAAGAGATATCTGGTTCAATTGGTATAATGACGTGATTATGCAATATGCTGATCTACACCTTGCGCTCACATTGTGCCAAACTTAAATGTGCAAGTGTACGTGAGAA AAGCACATGTGAATGTGAATTCTTTAATTCTTTGCTTATTATGTTAAAATTAGTCTTCATAGTCCACTGATGTGTATGCTTGAATAATGTCTATTTACTTTGGAATTTCAAGATTTCCAGCTTCAATG GTAATTTATAATTTCTCAGATCACCTTAAGAAATATTGAGATACTCTCCCACCTGAAAATAATCTGTTCTTTAACCCACCTGACTATGGGAGTAGCCAGGCAGGTGCCTCACTGGCTTCTTCAGACGA GGCTTCCTCAGGTGGATATATGACTATTAGGGGAAAAGAGGCTTTTGAGACAGCTTATTACCTCCTTCCCCTTTTTGAACTAAGTACATTGTCTCAGTCCCAGTATGAATTTGTCCCATTTGGGGTAT TTTTAAAATAAAAGATGGCTAACATGGAATCTGGGGCATAGCCTTGGCCTTTAATTATGGTTGTAAGCCCAAATAATGGCAGAGAAACACAGGGCTGTTTTTACAACAGAAAACTCAATATAAGTTTT ATATAAGAATCCTATAAAATTTGAACCAGAGCTCCTATTTAGTTGTTATAATGTCTCCTAAAGATCTTAAATGCTTCTAAAAGCTAATTATTATTCCAGAGCAACTTTTTCCTTTTCCCCCTTATAAA GTTTTTTTTTAAATCCAAAATCTTAGATTTCTGTGCCACAGCAAAATAAAATGATCAACAATTAAAGATCTGTACTTAAAATAGTACACCATTTTTAGTGGAGGGAGGGTGCATGCCTATATGATGGT AAGATTCTTTTGAACTCTAAGGACAATTCCTCATGGAAAAAATAAATTTCAGTGCATATTATAAAAATGATTTGCACTGTGTTAGCAAAATAAGGTGTTTTAGGTTGTATTTTAAAGACAATTCTAAA TCATTTCTCTGGAAAGCAAGACCTTAAATTCTTCTCTTTAATAGAACTGCTTTTATGCAAAGAGATGGTCTTAACATGGACTAAACAGTACATAACAATAATGTTTGTTATGTAAATAGTATATCACA TTTGCTTAGTAGCACAATTCAACAGCAGGCTGAAAGTCGTGGCTCCTCTGCTCAGATTGAGTTTTAAGTTACCTAATTTATGTAATCAGAATCTATTCTAGGTGGCCGTCAACGTAAACTGTGTTTCC CTATTATATCCCTCTGGAGACTGAGAATCAAATTAAATAGTCTTTCTTCAAAGCAGTACTGTAACATGAATGTATTTATCTCAGTCAACAGAACTTATATGCCCACTGTATGTGGAGCTTATTTCAAT GCTAATTTGGCTTAGTTAGCAGACCTAGAATCTGCCCAGGTGAGACCTAGAACAAAAATAGCTGGGGTGAAATGGATAAGAGAGGTAGAGGTATATGTCAAGGCAGAGCCCTATGAGGAAGGAAGAGT TTTCAAAGAATATGAGGAACATAGTGCTGAGAGTGTGGCTGCCTTCAGCACCGTACACCTAATCTAGAGAAAATATTTCCCATGTGGGAGGTCCTGTCTGCATTCAGTCCACCCTTTTCTGCCTGCTT CTTCCTCCAAGTGCCTCAACCTCTACATGCTCACTCTCCTCCCCTTCCCTCAGCCCATCTTGGTCTAAGCAGCTTTCACAATCCAAACCAAACATCACCAGCCACCCGCTGATAAGTCACCAGCATTT ACTTTCCTGAGTTACTTTTTCTCCATTCATTGAGACTATGGATTCATCCCAACTCCTTCTAAATCCCTCAACCATCCAGCTATATTTTGGCTAACCTTTGCCCTAGACACTCTACCAGATGTTAATGC AGTATCAAGTGTAAATTGTGTCACCCTATTCTGTTCTACCCTTTTCCCTGCTGCCGAAATATCTTGCTCTCCTCTACCTCATCCCCAAAGAGCCTATAAATTCAGAGTATCCAACCTTTTCATGGATT CACTCACTGTTGTTCAGTAATACAACTTCCATATTTTAAATAAATCATAAAAGATTTTTGCCTTCTATCAAAGTAGGAAACTTTATATTTATACATGATACAGAAATTGAACTATTTCTATCGTTCAG AATTTAGCATATAACAGGATTTTAAAGTGATTGAATTGCCATCCTAACTTGGATTTGTATTAGGTTATGAATGAATACTGTTGTTAGTCCAAGCTATTTGAATGTAAAGTTAAAATTCTCCAGCAATC CAGAATGACTTGTAACCCTTCAGTGGAATGGGAAATTTCTGGTATGCAAATAGGGTGGTGTTCCAGACATTTGTTTTATTGGTGGTGTTTGGGCCTTGAAACACATTTCTAATAGAATGACATATGGC AAAGGGTATTTAGATGGTCCTATGGGATCACAGAAGCCCATATGATTTAAAATATAGATAAAATAACACAAAATTGGGTACATAAGGGTTTAACCAGGCTTTCCTGGGTTAGACTAAGCCTCTAACCT CTGTTCCTATCCTGTTCTTATGGGAGGAAAAAAAATGTTCCATGGGATGAAAAGAAAATGCATTGACTTTGTAGTCTTTATTCTCCTAGCCGCACTTCGGGTATATCCAGAAGGAAGAGGAAATGCAA AGAGGAAGAAGATGTAATAGTTCTTCTCTCCAGCTAGGTGCACTTGAGGTTGTTCATAAATGTAAAATTATGTCAGGTTTCTAACATGGGACACTGCACACAGTTGTCTGACCTGATGAACCATCCCA TTTGAAAGTATAGATTATTATTATTTCTTGTAGTATTTGGTTGTTTTCCATCTCATTCATGAACAACTCAACCTGATAGTAGTATCCAATAAATGCCTTTCAGGGCTCAGGAATGAATTGACATCCTA GTTAAGAAATGAGACTTAATAATGGAGACTGAATGAGGCGGTTTGTATTAAATTATATGCCATGAAGTGTTCATTTTAGCTTTAACCTAATTATGACTGTACCACCATGAAGTACAGAATGAAAAATT ATATATATGGGGGGGAAACAGAATGAATATCTGATTCTTTTGAATGCTTGTGGAAATCTTTGAGATCGTGCAGGGCATACCACAAAATAGCCTTTAGAACAGATACCCAATTTTACAGTTCATAGGAC AACATCAAACATTAGTAAGTCTAAATAAGATGAATAGAATTTTTGTTATGTAAATTTTGCTAGAACAGTCTATTTTCTTGCACCCCTCAAGTTAACCTCTTAAAAAAATGAATGTATAATTTCTACCG AAAGAATATCAGAGAGAATCTCTCTGGCCTATAGTGTTAAAATATTGTTCACAAATCCTGATTAGTTAAGTGCATACATTATGAAACTTACAGAATAAAACTTATTATACATCTCTTTCTTAAATTAA TATCTTTACACATTTTCAACTGGCTCCCCAAGTCTGATAAGGAAGGATTAAAAGAAAAAAGAAATGTATTAGTTGGGTGGCCAAGGAGTTTCCTTTGTAATGTTGAGAGACTTCCGCTTTCTGAATTT CGCTGGTTCTCTAAGGTAAAAGAGTTAAATAGTACCCTTGTTCACCAAGGAAAGTGATCCAAACTATATATCTAGTGCAGATATTTCCTTTGCATTATTTAGTCTTCTCTGGAGAGAAAATACAGTTT CCCCTTCCTCTTTCTCTTCACATTTACTCTTTTCAACCCAAAATAAGAGACATAGAAAGCAAACCACAGCCAGTTTGGCATCTTCTCAGTGCTACTAGTATAGGCACATACACATACACAGTCTCAGC AAGGTTATAAAGAACCCTGTCAGGTCCACTTGCAACATGGCCTTGCTACTTGGATTAGCTCCTTTAAGCCTGAAAATAACTTTCCTGGTCATGGAAGAACTGGACGCATCTTTTAACTTATGAAATAG AAGTTGAACTTGAAAACTCTTTTTAAAAAATCCTGGTTTTGCAGGACAGCTACATAATGAATGTATATATTAAGACTGTAGCTGAATTGCACATGAAATCAGATTGCCAACTTCTTGACTTTCAATGT TAGACATTTATCCTTAAGTTGTGAGCGATATATGTAGCATGCTGTGAAATGTCTGTTATAGCTCTTTAATTCATCAGTATTAATACAGAATTATCATTTGCGTTTCTTGGTACTTTTTATTCAATGTA ATCAGAAGCTGTGATGTTTTGCCTTTGTAGTCCTGTGCTTTGTTACTGTAATTTTTTTTTTTTTTTTACGAAGCACGTGACTGGACTAATGTAAGGCAGATGACGTGATCTTTAAGACTGCTATATAT ATCAGTCTCTTACTCTATAAGGTTTTAAATTAGAATAAGCTTTTATCAAATAGATAATTGATGCAATTTAGGATTCACGCAAGTTTCAGTGTCAAATGGCGGTCTTATAGTTTCAATTCTGAAAATAG CAAACTTAATAAACAGCCACTTTAAACTTGTTCTGGCAAACCAGACCCTGCTGTAGATATAGTCTAAGGTAGTTAACCATATAAGCCTTTTCAACTCTTAATGCCCTCCACATGAATCAGCAGTTAAG AAGGTTCTAGAACCCATGAAAGCTTTTGTATGTATTACTAGGTTTTGTTTTTCTTATGTTTGCTGATTTTACAGTTCTGACTAAAGCTGACCTAAATGGATCAGTTTATGTGTAATATTCTAGTGCTT TAATGACTCTTTTTTTCTTTGGAGGGAGGGTAACATTATTTGGACAGATGCAGAAGGAACTGTTAGTGAGTCAAGACAAACACATCTGAAATAAAGGAACTGTGTATTAACATGTTAACAATTCATAA CTGCACTTTTTATGACATTTTGAAAATCTATTTATAGGTACAGAACAATGGGTTTTGTTAAACTGTATCACATTTATACTTGCAGAAATTTATTTCATTGTTATTAGTAGGAATTTTATTGGTTCAAT AAAATTGGCAAAACTGAACACCAA
hide sequence
RefSeq Acc Id:
XM_047426416 ⟹ XP_047282372
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 11 95,165,513 - 95,206,124 (-) NCBI
RefSeq Acc Id:
XM_054367754 ⟹ XP_054223729
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 11 95,172,632 - 95,239,638 (-) NCBI
RefSeq Acc Id:
XM_054367755 ⟹ XP_054223730
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 11 95,172,632 - 95,239,448 (-) NCBI
RefSeq Acc Id:
XM_054367756 ⟹ XP_054223731
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 11 95,172,632 - 95,213,240 (-) NCBI
RefSeq Acc Id:
NP_653266 ⟸ NM_144665
- Peptide Label:
isoform 1
- UniProtKB:
B7Z7P9 (UniProtKB/Swiss-Prot), Q96AD1 (UniProtKB/Swiss-Prot), P58005 (UniProtKB/Swiss-Prot)
- Sequence:
MNRGGGSPSAAANYLLCTNCRKVLRKDKRIRVSQPLTRGPSAFIPEKEVVQANTVDERTNFLVEEYSTSGRLDNITQVMSLHTQYLESFLRSQFYMLRMDGPLPLPYRHYIAIMAAARHQCSYLINMH VDEFLKTGGIAEWLNGLEYVPQRLKNLNEINKLLAHRPWLITKEHIQKLVKTGENNWSLPELVHAVVLLAHYHALASFVFGSGINPERDPEISNGFRLISVNNFCVCDLANDNNIENASLSGSNFGIV DSLSELEALMERMKRLQEEREDEEASQEEMSTRFEKEKKESLFVVSGDTFHSFPHSDFEDDMIITSDVSRYIEDPGFGYEDFARRGEEHLPTFRAQDYTWENHGFSLVNRLYSDIGHLLDEKFRMVYN LTYNTMATHEDVDTTMLRRALFNYVHCMFGIRYDDYDYGEVNQLLERSLKVYIKTVTCYPERTTKRMYDSYWRQFKHSEKVHVNLLLMEARMQAELLYALRAITRHLT
hide sequence
RefSeq Acc Id:
NP_001258523 ⟸ NM_001271594
- Peptide Label:
isoform 2
- UniProtKB:
P58005 (UniProtKB/Swiss-Prot)
- Sequence:
MSLHTQYLESFLRSQFYMLRMDGPLPLPYRHYIAIMKLVKTGENNWSLPELVHAVVLLAHYHALASFVFGSGINPERDPEISNGFRLISVNNFCVCDLANDNNIENASLSGSNFGIVDSLSELEALME RMKRLQEEREDEEASQEEMSTRFEKEKKESLFVVSGDTFHSFPHSDFEDDMIITSDVSRYIEDPGFGYEDFARRGEEHLPTFRAQDYTWENHGFSLVNRLYSDIGHLLDEKFRMVYNLTYNTMATHED VDTTMLRRALFNYVHCMFGIRYDDYDYGEVNQLLERSLKVYIKTVTCYPERTTKRMYDSYWRQFKHSEKVHVNLLLMEARMQAELLYALRAITRHLT
hide sequence
RefSeq Acc Id:
XP_011540916 ⟸ XM_011542614
- Peptide Label:
isoform X1
- Sequence:
MDKDKRIRVSQPLTRGPSAFIPEKEVVQANTVDERTNFLVEEYSTSGRLDNITQVMSLHTQYLESFLRSQFYMLRMDGPLPLPYRHYIAIMAAARHQCSYLINMHVDEFLKTGGIAEWLNGLEYVPQR LKNLNEINKLLAHRPWLITKEHIQKLVKTGENNWSLPELVHAVVLLAHYHALASFVFGSGINPERDPEISNGFRLISVNNFCVCDLANDNNIENASLSGSNFGIVDSLSELEALMERMKRLQEEREDE EASQEEMSTRFEKEKKESLFVVSGDTFHSFPHSDFEDDMIITSDVSRYIEDPGFGYEDFARRGEEHLPTFRAQDYTWENHGFSLVNRLYSDIGHLLDEKFRMVYNLTYNTMATHEDVDTTMLRRALFN YVHCMFGIRYDDYDYGEVNQLLERSLKVYIKTVTCYPERTTKRMYDSYWRQFKHSEKVHVNLLLMEARMQAELLYALRAITRHLT
hide sequence
RefSeq Acc Id:
XP_024304123 ⟸ XM_024448355
- Peptide Label:
isoform X2
- Sequence:
MSLHTQYLESFLRSQFYMLRMDGPLPLPYRHYIAIMAAARHQCSYLINMHVDEFLKTGGIAEWLNGLEYVPQRLKNLNEINKLLAHRPWLITKEHIQKLVKTGENNWSLPELVHAVVLLAHYHALASF VFGSGINPERDPEISNGFRLISVNNFCVCDLANDNNIENASLSGSNFGIVDSLSELEALMERMKRLQEEREDEEASQEEMSTRFEKEKKESLFVVSGDTFHSFPHSDFEDDMIITSDVSRYIEDPGFG YEDFARRGEEHLPTFRAQDYTWENHGFSLVNRLYSDIGHLLDEKFRMVYNLTYNTMATHEDVDTTMLRRALFNYVHCMFGIRYDDYDYGEVNQLLERSLKVYIKTVTCYPERTTKRMYDSYWRQFKHS EKVHVNLLLMEARMQAELLYALRAITRHLT
hide sequence
Ensembl Acc Id:
ENSP00000489281 ⟸ ENST00000634898
Ensembl Acc Id:
ENSP00000439580 ⟸ ENST00000542176
Ensembl Acc Id:
ENSP00000407008 ⟸ ENST00000416495
Ensembl Acc Id:
ENSP00000441927 ⟸ ENST00000536441
Ensembl Acc Id:
ENSP00000278499 ⟸ ENST00000278499
RefSeq Acc Id:
XP_047282372 ⟸ XM_047426416
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_054223729 ⟸ XM_054367754
- Peptide Label:
isoform X1
RefSeq Acc Id:
XP_054223730 ⟸ XM_054367755
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_054223731 ⟸ XM_054367756
- Peptide Label:
isoform X2
RGD ID: 6788782
Promoter ID: HG_KWN:13988
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, CD4+TCell_12Hour, HeLa_S3, K562, Lymphoblastoid, NB4
Transcripts: ENST00000393234, NM_144665, UC001PFL.1
Position: Human Assembly Chr Position (strand) Source Build 36 11 94,603,911 - 94,604,411 (-) MPROMDB